https://rjrindex.com/articles/phenotypic-evolution-of-circulating-tumor-plasma-cells-across-mgus-smm-and-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-national-analysis-on-alk-anaplastic-large-cell-lymphomas-community-based-care-linked-to-similar 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multi-omics-profiling-reveals-an-immunosuppressive-microenvironment-and-prl-3-as-a-therapeutic-targe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/synergistic-vulnerability-of-aggressive-b-cell-lymphoma-to-combined-mcl-1-inhibition-and-car-t-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-malignant-extracellular-matrix-drives-leukemia-transformation-through-reprogramming-of-pre-leuke 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-gecacitinib-in-thrombocytopenic-myelofibrosis-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-cytokine-release-syndrome-and-neurotoxicity-in-patients-receiving-epcoritamab-or-gl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dot1lmenin-inhibitors-target-replication-fork-plasticity-and-create-novel-vulnerability-to-parp-inh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-early-immunologic-decline-in-acquired-hemophilia-a-a-case-for-prophylactic-rituximab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hermansky-pudlak-syndrome-and-prolonged-activated-partial-thromboplastin-time 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characteristics-and-outcomes-for-patients-with-concomitant-myeloproliferative-neoplasms-mpn-and-au 2026-08-17 monthly 0.7 https://rjrindex.com/articles/age-related-differences-in-presentation-among-pediatric-adolescent-and-young-adults-with-mixed-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-septic-shock-in-immune-thrombocytopenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longitudinal-analysis-of-t-cell-phenotype-and-function-during-bispecific-antibody-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zanubrutinib-combined-with-bendamustine-and-rituximab-in-previously-untreated-patients-with-advanced 2026-08-17 monthly 0.7 https://rjrindex.com/articles/circulating-glycornas-a-novel-class-of-glycoconjugates-in-blood-and-implications-for-erythrocyte-bi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mechanism-of-butyrate-remodeled-calcium-signaling-in-nk-cells-reverses-daratumumab-resistance-in-mul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-rates-of-severe-maternal-morbidity-and-preterm-birth-among-pregnant-individuals-with-sickle-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/atr-inhibition-with-nucleoside-analog-therapy-synergistically-overcomes-chemoresistance-and-reprogra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tp53-activation-by-the-natural-quassinoid-brusatol-enhances-venetoclax-efficacy-and-overcomes-resist 2026-08-17 monthly 0.7 https://rjrindex.com/articles/developing-transcriptomic-signature-for-idh1-and-idh2-acute-leukemia-and-the-demonstration-of-high-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-dosages-bh3-profiling-and-bcl-2-expression-predict-response-to-azacitidine-venetoclax 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mynerva-gimema-aml1919-ameliorate-trial-early-intensification-in-flt3-mutated-acute-myeloid-leukemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-second-line-therapies-following-upfront-daratumumab-plus-bortezomib-cyclophosphami 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sequential-bcma-and-gprc5d-targeted-bispecific-antibody-therapy-in-multiple-myeloma-real-world-out 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-phase-ii-multicentre-study-to-evaluate-the-efficacy-and-safety-of-birelentinib 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessing-the-influence-of-live-and-online-enduring-cme-activities-presented-at-the-66th-ash-annual 2026-08-17 monthly 0.7 https://rjrindex.com/articles/neutrophil-tlr9-is-a-therapeutic-target-for-acute-chest-syndrome-in-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/daratumumab-based-therapy-for-newly-diagnosed-multiple-myeloma-patients-with-renal-impairmenta-mul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-efficacy-and-safety-of-polatuzumab-vedotin-rituximab-and-zanubrutinib-pola-z-r-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-between-inflammatory-and-hemolysis-markers-in-children-with-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/late-immune-effector-cell-associated-hematotoxicity-icaht-in-patients-with-relapsed-refractory-lar 2026-08-17 monthly 0.7 https://rjrindex.com/articles/design-and-characterization-of-novel-albumin-based-oxygen-carriers-as-an-alternative-to-whole-blood 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disparities-in-diagnosis-and-management-of-myelodysplastic-syndromes-in-a-brazilian-cancer-center-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acute-myeloid-leukemia-mortality-in-us-older-adults-a-45-year-nationwide-analysis-with-forecastin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/retrospective-analysis-of-r-cdop-efficacy-and-safety-in-frail-patients-with-dlbcl-compared-to-r-chop 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gastrointestinal-and-hepatobiliary-toxicities-associated-with-bispecific-antibody-therapy-in-hematol 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thalidomide-in-beta-thalassemia-a-systematic-review-and-meta-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anticoagulation-management-and-outcomes-in-cancer-associated-ovarian-and-renal-vein-thrombosis-a-mu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cell-cycle-dependent-and-independent-regulation-of-akt-activity-in-germinal-center-b-cell-like-diffu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-novel-allosteric-nek7-inhibitor-ofirnoflast-ht-6184-demonstrates-robust-and-sustained-hematolo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-incidence-of-htlv-1-infection-in-andean-highlanders-with-nfkb1-haplotype 2026-08-17 monthly 0.7 https://rjrindex.com/articles/detection-of-npm1-mutation-in-acute-myeloid-leukemia-by-multiple-droplet-digital-pcr-and-its-clinica 2026-08-17 monthly 0.7 https://rjrindex.com/articles/more-than-iron-embedding-gynecologic-care-in-a-telemedicine-ida-platform 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-non-canonical-glycolytic-endpoint-supports-hsc-survival-and-function 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multi-omics-reveals-immune-features-in-immune-and-non-immune-cells-an-ifn-ghifn-a-b2m-positive-feed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/validation-of-measurable-residual-disease-as-a-surrogate-endpoint-in-acute-myeloid-leukemia-a-harmo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/alidhe-an-ongoing-open-label-phase-3b-study-investigating-ivosidenib-with-azacitidine-in-clinical-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/monitoring-of-cns-involvement-in-aml-using-ultrahigh-sensitivity-next-generation-sequencing-of-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-efficacy-and-safety-of-rilzabrutinib-an-oral-bruton-tyrosine-kinase-btk-inhibitor-in-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/red-cell-rheology-predicts-acute-chest-syndrome-and-vaso-occlusive-events-in-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epigenetic-silencing-via-sp140-and-h3k27me3-restricts-immunogenic-viral-antigen-expression-in-ebv-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-river-81-a-phase-2-study-of-romaciclib-rvu120-venetoclax-in-patients-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-2a-study-of-budoprutug-in-patients-with-immune-thrombocytopenia-itp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improved-long-term-tolerability-and-efficacy-of-asciminib-based-combination-therapies-in-newly-diagn 2026-08-17 monthly 0.7 https://rjrindex.com/articles/kinetics-of-circulating-multiple-myeloma-cells-cmmcs-in-patients-undergoing-standard-of-care-anti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blastic-plasmacytoid-dendritic-cell-neoplasm-bpdcn-international-registry-assessment-of-the-allo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/statin-use-and-the-risk-of-acute-myeloid-leukemia-a-retrospective-propensity-matched-cohort-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-csf1r-to-overcome-myeloid-cell-suppression-in-cart-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/changes-in-long-term-bone-health-in-patients-receiving-avapritinib-for-the-treatment-of-indolent-sys 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-remote-patient-monitoring-in-enabling-outpatient-step-up-dosing-for-bispecifics-at 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-overall-survival-and-time-to-next-treatment-among-elderly-united-states-medicare-benefici 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mortality-in-sickle-cell-disease-a-report-from-the-grndad-registry 2026-08-17 monthly 0.7 https://rjrindex.com/articles/subcutaneous-every-four-week-maintenance-dosing-of-a-novel-protein-s-antibody-is-well-tolerated-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-cevostamab-consolidation-following-bcma-car-t-cell-therapy-preliminary-safety-ef 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-a-fully-human-bcma-car-t-cell-therapy-for-high-risk-newly-diagnosed-transplan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-molecular-landscape-of-patients-with-malignant-histiocytosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-updated-systematic-review-and-meta-analysis-of-caplacizumab-for-immune-thromboticthrombocytopenic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-of-cytokine-release-syndrome-crs-immune-effector-cell-associated-neurotoxicity-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-3-study-inmind-of-tafasitamab-plus-lenalidomide-and-rituximab-for-relapsed-or-refractory-fol 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pharmacokinetics-of-ferric-maltol-oral-suspension-in-children-and-adolescents-1-month-to-17-years 2026-08-17 monthly 0.7 https://rjrindex.com/articles/quality-adjusted-survival-analysis-of-neurologic-events-with-ciltacabtagene-autoleucel-cilta-cel-v 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bioequivalence-of-ruxolitinib-once-daily-extended-release-vs-twice-daily-immediate-release-tablets-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-american-society-of-hematology-quality-improvement-training-institute-impact-on-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-independent-multi-center-analysis-of-the-post-approval-utilization-and-efficacy-of-pacritinib-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/toxicity-and-efficacy-profile-of-cardioprotective-vs-conventional-doxorubicin-a-meta-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/son-maintains-innate-immune-homeostasis-in-hscs-via-splicing-and-retroelement-control 2026-08-17 monthly 0.7 https://rjrindex.com/articles/overcoming-surveillance-gaps-deep-learning-for-accurate-detection-and-chronicity-classification-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma-treatment-patterns-at-florida-can 2026-08-17 monthly 0.7 https://rjrindex.com/articles/haplo-identical-transplantation-in-patients-with-myelofibrosis-a-phase-2-prospective-multicentric-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/construction-and-validation-of-a-prediction-model-for-extracorporeal-circuit-clotting-risk-during-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/front-line-treatment-of-philadelphia-negative-b-cell-acute-lymphoblastic-leukemia-with-hypercvad-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/microrna-142-improves-il1rap-car-t-cell-activity-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-two-genetically-distinct-subtypes-of-c5-diffuse-large-b-cell-lymphoma-dlbcl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-and-mortality-to-incidence-ratio-mir-in-refractory-anemia-with-excess-blasts-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hematologic-adverse-events-associated-with-immune-checkpoint-inhibitors-a-real-world-pharmacovigila 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venous-thromboembolism-in-multiple-myeloma-patients-treated-with-bcma-directed-car-t-cell-therapy-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/external-validation-of-the-intermountain-risk-scores-for-post-discharge-pd-thrombosis-and-bleeding 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beyond-tp53-molecular-ipss-genes-multihit-status-revisited 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapeutic-drug-monitoring-guided-individualized-dosing-of-multiple-btk-inhibitors-combined-with-vo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combined-tcr-seq-and-single-cell-rna-seq-reveal-distinct-origins-for-antiviral-immunity-after-post-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/infections-in-patients-with-aggressive-b-cell-lymphomas-treated-with-cd3xcd20-bispecific-antibodies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mednext-based-automatic-segmentation-of-18f-fdg-pet-images-in-angioimmunoblastic-t-cell-lymphoma-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bgb-3111-218-single-arm-open-label-multicenter-study-of-the-bruton-tyrosine-kinase-btk-inhibito 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transcriptomic-identification-of-functionally-potent-human-hematopoietic-stem-and-progenitor-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/line-of-therapy-stratified-efficacy-of-belumosudil-in-cgvhd-real-world-evidence 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-central-nervous-system-prophylaxis-on-survival-outcomes-in-patients-with-primary-testicula 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-disparities-in-non-hodgkin-lymphoma-related-mortality-along-the-us-mexico-border 2026-08-17 monthly 0.7 https://rjrindex.com/articles/upregulation-of-extracellular-matrix-remodeling-gene-set-drives-progression-and-poor-prognosis-in-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/platelet-dysfunction-in-ehlers-danlos-syndrome-is-associated-with-low-gpvi-and-par1-expression-on-pl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-the-cd38-nad-axis-alleviates-antibody-driven-cytopenia-in-autoimmune-disorders-without-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-patterns-of-acute-myeloid-leukemia-in-the-united-states-from-1999-to-2021-analysis-by-age 2026-08-17 monthly 0.7 https://rjrindex.com/articles/grndma-initial-reports-from-an-adult-sickle-cell-registry-in-malawi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-data-of-lisocabtagene-maraleucel-as-second-line-therapy-for-patients-with-large-b-cell-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-onset-t-cell-large-granular-lymphocytic-leukemia-in-a-24-year-old-woman-a-rare-case-with-conf 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-safety-and-effectiveness-of-direct-oral-anticoagulants-and-low-molecular-weight-heparin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-adult-t-cell-acute-lymphoblastic-leukemialymphoma-in-a-real-world-cohort-a-single-inst 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-triple-vs-quadruple-therapy-in-transplant-ineligible-multiplemyeloma-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lineage-specific-distribution-of-clonal-hematopoiesis-of-indeterminate-potential-across-mature-hemat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-monocytic-phenotype-and-npm1-mutation-status-in-acute-myeloid-leukemia-when-treated-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-the-mif-cd74cd44-signaling-axis-as-a-therapeutic-target-in-pediatric-acute-myeloi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/liposomal-mitoxantrone-demonstrates-superiority-to-traditional-mitoxantrone-in-the-treatment-of-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-in-patients-with-cll-and-cardiovascular-comorbidities-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-2-year-efficacy-and-safety-of-iptacopan-monotherapy-in-patients-with-paroxysmal-nocturnal-hemogl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-bendamustine-rituximab-and-venetoclax-br-ven-for-the-front-line-treatment-of-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/antithrombin-deficiency-venous-thromboembolism-risk-and-peripartum-antithrombin-supplementation-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd19-car-t-cell-therapy-in-aml1-eto-positive-acute-myeloid-leukemia-a-multi-omics-analysis-of-respo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acute-myeloid-leukemia-associated-pneumonia-mortality-trends-1999-2023-and-arima-based-projections 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prolonged-thrombocytopenia-following-diverse-car-t-cell-therapies-high-incidence-inflammatory-risk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lv2019-car-t-cells-for-methotrexate-relapsedrefractory-primary-or-secondary-cns-lymphoma-with-pare 2026-08-17 monthly 0.7 https://rjrindex.com/articles/wu-cart-007-a-cd7-directed-allogeneic-car-t-cell-therapy-for-rr-t-cell-acute-lymphoblastic-leukemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rural-urban-disparities-in-survival-rates-in-adult-hodgkin-lymphoma-a-population-based-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-fxia-modified-clot-waveform-analysis-for-estimation-of-factor-viii-level-and-emicizumab-concentrat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unconventional-mechanism-of-estrogen-induced-thrombosis-the-role-of-tissue-factor-and-non-canonical 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-hiv-status-on-clinical-outcomes-in-hodgkin-lymphoma-a-national-database-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prophylactic-and-preemptive-donor-lymphocyte-infusion-dli-improves-outcomes-in-refractory-aml-unde 2026-08-17 monthly 0.7 https://rjrindex.com/articles/living-the-recovery-one-year-qol-outcomes-for-patients-receiving-ptcy-gvhd-prophylaxis-on-the-acces 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-reconstitution-and-infectious-complications-following-car-t-cell-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-second-primary-malignancies-and-leukemic-transformation-in-patients-with-philadelphia-chromo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thrombosis-and-outcomes-in-hematologic-neoplasia-experience-from-a-specialized-cancer-center-in-a-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-demographics-and-survival-outcomes-in-newly-diagnosed-cux1-mutated-acute 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-ibrutinib-as-a-first-line-agent-for-mantle-cell-lymphoma-a-systematic-revie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bone-marrow-adipocytes-bma-as-a-novel-biomarker-of-molecular-response-in-patients-with-essential-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/baseline-18f-fdg-pet-biomarkers-of-host-and-tumor-predict-efficacy-and-crs-in-multiple-myeloma-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effect-of-duffy-status-on-patients-with-breast-cancer-receiving-cyclin-dependent-kinase-46-inhibito 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longitudinal-trends-1999-2023-and-forecasted-mortality-2024-2030-in-sepsis-associated-mortality 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-apoe-genotypes-in-older-adults-with-acute-myeloid-leukemia-insights-from-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-responses-and-survival-of-newly-diagnosed-older-or-unfit-patients-pts-with-idh12-mutate 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unsupervised-clustering-of-ddx41-mutants-informs-on-the-somatic-landscape-of-single-germline-hits 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dysregulated-lung-microbiota-impaired-hematopoietic-stem-cell-function-in-mice-with-pulmonary-diseas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transcriptome-sequencing-of-hodgkin-lymphoma-hodgkin-and-reed-stenberg-cells-reveals-escape-from-nk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-the-team-conditioning-for-autologous-stem-cell-transplantation-in-lymphoma-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-influence-of-racial-socioeconomic-and-geographic-disparities-in-the-survival-of-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/endogenous-regulation-of-inflammatory-response-as-a-determinant-of-durable-remission-without-stem-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-antibiotic-use-in-early-fever-after-haploidentical-hematopoietic-stem-cell-transplantation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adverse-events-in-relapsedrefractory-multiple-myeloma-rrmm-patients-receiving-bi-specific-t-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-pediatric-patients-transplanted-for-b-all-with-high-risk-cytogenetics-a-20-year-experie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-mk-1045-a-novel-cd19xcd3-t-cell-engager-in-participants-with-relapsed-or-refracto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-murine-monoclonal-antibody-to-integrin-aiibv3-that-inhibits-protein-disulfide-isomerase-binding-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-preliminary-efficacy-of-combined-lenalidomide-and-cd19-car-t-cell-therapy-in-relapsedref 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-systemic-high-dose-mtx-and-btk-inhibitors-on-outcomes-in-vitreoretinal-lymphoma-a-multice 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-hyperfibrinolysis-a-novel-prevention-and-reversal-strategy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ai-powered-precision-unmasking-hidden-treatment-optimizations-for-lower-risk-myelodysplastic-syndro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/infection-rates-and-mortality-in-multiple-myeloma-impact-of-blood-counts-and-igg-levels-over-time 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeted-disruption-of-bcl11a-znf4-enhances-fetal-hemoglobin-in-v-thalassemia-and-sickle-cell-diseas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-b7-h3-specific-binder-enables-effective-car-t-cell-therapy-in-an-acute-myeloid-leukemia-expe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/poor-survival-and-temporal-trends-in-blastic-plasmacytoid-dendritic-cell-neoplasm-a-seer-2000-2022 2026-08-17 monthly 0.7 https://rjrindex.com/articles/azacitidine-aza-and-donor-lymphocyte-infusion-dli-is-a-viable-salvage-approach-for-chimerism-onl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-on-first-line-early-switch-to-kpd-regimen-in-the-treatment-of-multiple-myeloma-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pediatric-inspired-bfm-protocol-in-adolescent-and-young-adults-aya-with-acute-lymphoblastic-leuk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pyramidh-a-phase-3-study-of-ivosidenib-monotherapy-or-azacitidine-monotherapy-in-patients-with-muta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-utility-of-the-elts-score-in-pediatric-chronic-myeloid-leukemia-is-it-a-valid-clinical-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-polatuzumab-vedotin-based-regimens-in-newly-diagnosed-diffuse-large-b-cell-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rare-but-not-forgotten-a-case-of-evans-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/red-blood-cell-transfusions-for-adolescent-patients-with-sickle-cell-disease-amp-short-stature-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/point-of-care-hemoglobin-measurement-to-streamline-clinical-decision-making-a-single-center-experie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-genotyping-and-methylome-sequencing-scgem-seq-resolves-cell-states-and-clonal-hierarch 2026-08-17 monthly 0.7 https://rjrindex.com/articles/initial-results-of-a-cruk-phase-iii-first-in-human-trial-of-the-car-t-cell-engager-protein-aleta-0 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-during-btki-treatment-for-chronic-lymphocytic-leukemia-insights-from-remote-therapeutic-mo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/what-remains-matters-real-world-impact-of-measurable-residual-disease-testing-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/durability-of-complete-response-outperforms-complete-response-rates-as-a-surrogate-endpoint-for-adva 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ppm1d-mutations-confer-resistance-to-venetoclax-in-pre-leukemic-and-aml-populations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-center-experience-with-mitoxantrone-hydrochloride-liposome-based-therapy-for-patients-with-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-survival-of-idh-mutant-patients-in-china-before-idh-inhibitor-era-a-multicenter-retrospe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/arv-393-a-protac-bcl6-degrader-combined-with-the-cd20cd3-bispecific-glofitamab-in-a-preclinical-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-up-to-4-years-of-once-weekly-efanesoctocog-alfa-prophylaxis-in-previously-treated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ferroportin-q248h-mutation-is-associated-with-the-less-weight-loss-in-persons-with-hiv-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-collective-non-mutational-transition-governs-the-development-of-chronic-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-laser-based-nanoparticle-platform-to-enhance-t-cell-mediated-immunity-without-direct-tumor-access 2026-08-17 monthly 0.7 https://rjrindex.com/articles/asciminib-for-relapsed-or-refractory-philadelphia-positive-acute-lymphoblastic-leukemia-ph-all-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-treatment-outcomes-of-acute-lymphoblastic-leukemia-in-japan-progress-and-unmet-n 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-the-sanctuary-sites-allogeneic-cd19-car-t-therapy-for-extramedullary-relapsed-b-cell-acut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/plasma-derived-vwffviii-prophylaxis-in-children-under-6-with-vwd-first-results-from-wil-33 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-co-occurring-flt3-mutations-across-molecular-subgroups-in-intensively-treated-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/updated-clinical-data-and-biomarker-analyses-from-the-phase-1-study-of-dr-01-a-non-fucosylated-anti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pharmacodynamic-analysis-of-agave-201-indicates-changes-in-csf-1r-expressing-cells-and-associated-bi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/antibody-and-equipment-free-ultralow-cost-point-of-care-sickle-cell-disease-diagnostic-an-equitab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/etoposide-cytarabine-plus-g-csf-mitigates-daratumumab-associated-impairment-on-stem-cell-mobilizati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-public-versus-private-health-care-services-in-the-treatment-of-diffuse-large-b-cell-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/antiphospholipid-antibodies-anti-v2gpib2gpi-prime-neutrophil-nlrp3-inflammasome-activation-via-tl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fast4tma-a-national-rapid-adamts13-testing-initiative-for-tma-patients-2025-update 2026-08-17 monthly 0.7 https://rjrindex.com/articles/next-generation-sequencing-ngs-of-dna-isolated-from-nail-specimens-and-run-in-parallel-with-tumor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/btk-inhibition-drives-mobilization-and-compartmental-shifts-of-cll-subclones 2026-08-17 monthly 0.7 https://rjrindex.com/articles/letermovir-prophylaxis-for-cytomegalovirus-and-immune-reconstitution-after-allogeneic-hematopoietic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unmasking-the-unknown-a-case-of-bone-marrow-carcinomatosis-with-elusive-primary 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-asciminib-in-relapsedrefractory-philadelphia-chromosome-positive-b-all-and-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/determinants-of-survival-in-primary-cutaneous-anaplastic-large-cell-lymphoma-pcalcl-analysis-of-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tada1-plays-a-regulatory-role-in-erythropoiesis-and-the-expression-of-hbg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transcriptomic-analysis-uncovers-hidden-intronic-and-synonymous-pathogenic-variants-in-red-cell-memb 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-early-bacteremia-on-clinical-outcomes-following-allogeneic-hematopoietic-cell-transplantat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/loss-of-cell-cycle-regulators-rb1-and-cdkn2a2b-induces-cll-with-distinct-disease-kinetics-in-murine 2026-08-17 monthly 0.7 https://rjrindex.com/articles/factors-influencing-outcomes-in-therapy-related-myeloid-neoplasms-following-allogeneic-hematopoietic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mechanism-of-ruxolitinib-is-better-in-treating-hydrxyurea-resistan-polycythemia-vera-pv-than-essen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/golcadomide-golca-a-potential-first-in-class-oral-celmod-agent-plus-r-chop-in-patients-pts 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-3-study-of-vamotinib-pf-114-versus-high-dose-imatinib 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dynamic-machine-learning-based-prediction-of-major-bleeding-in-patients-receiving-anticoagulant-ther 2026-08-17 monthly 0.7 https://rjrindex.com/articles/car-t-efficacy-in-large-b-cell-lymphoma-is-shaped-by-neoantigen-driven-epitope-spreading-and-limited 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rising-mortality-and-burden-of-multiple-myeloma-in-adolescents-and-young-adults-a-sex-and-income-st 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparison-of-picc-lines-vs-tunneled-catheters-hickmanportacaths-in-stem-cell-transplantation-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinician-assessed-eastern-cooperative-oncology-group-performance-status-vs-patient-reported-health 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-outcomes-and-hospitalization-of-patients-with-multiple-myeloma-and-hip-fractures-an-analy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clostridium-difficile-infection-in-sickle-cell-disease-trends-predictors-and-complications-in-hos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adult-hemophagocytic-lymphohistiocytosis-a-multicenter-retrospective-analysis-of-etiology-and-impac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inverse-association-of-legacy-pfas-mixture-exposure-with-neutrophil-to-lymphocyte-ratio-in-united-st 2026-08-17 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomics-identified-dynamic-and-spatial-resolved-niche-cell-and-signal-architecture-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ultra-high-risk-multiple-myeloma-with-early-mortality-despite-quad-class-and-bcma-directed-therapies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/synergistic-correction-of-polycythemia-vera-phenotype-via-dual-targeting-of-jak2-and-gas6-in-jak2-ex 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-genetic-comparison-of-epstein-barr-virus-associated-polymorphic-lymphoproliferative-disorder-and-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tgm2-as-a-novel-therapeutic-target-in-venetoclax-resistant-aml-disrupting-histone-serotonylation-dr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mapping-genomic-responses-to-kit-receptor-tyrosine-kinase-signaling-in-erythroid-progenitors 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-immune-therapeutic-salvage-strategy-for-functional-high-risk-fhr-multiple-myeloma-mm-incorp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cancer-selective-targeting-of-the-nf-kb-pathway-via-gadd45vmkk7-inhibition-results-from-the-phase 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fcr-iiven-combination-for-cll-cheap-but-fierce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chromatin-remodeler-satb2-thorough-bmi1prc1-activity-controls-transformation-and-reprogramming-of-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/peripheral-blood-b-cell-early-regeneration-predicts-clinical-relapse-and-guides-preemptive-therapy-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/demographic-and-laboratory-features-of-monoclonal-gammopathy-of-undetermined-significance-mgus-sub 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-vs-clinical-trial-data-of-belantamab-mafodotins-ocular-toxicities-a-comparative-analys 2026-08-17 monthly 0.7 https://rjrindex.com/articles/decreased-serum-total-cholesterol-is-associated-with-worse-outcomes-among-patients-with-myeloprolife 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tp53-aberrant-mantle-cell-lymphoma-treated-with-first-line-systemic-therapy-a-real-world-analysis-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ai-powered-leukemia-intelligent-virtual-examiner-live-for-rapid-and-accurate-diagnosis-of-acute-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-morbidity-in-adults-with-non-transfusion-dependent-thalassemia-referred-to-us-specialty-cente 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-with-a-combination-of-treosulfan-and-fludarabine-in-acute-myeloid-leukemia-and-myelodysplas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-prevalence-of-clonal-hematopoiesis-in-fanconi-anemia-revealed-by-whole-exome-sequencing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/diffuse-fractures-in-a-neonate-with-homozygous-uros-c73r-congenital-erythropoietic-porphyria-an-unr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/azd0120-gc012f-a-bcmacd19-dual-targeting-fastcar-t-cell-therapy-demonstrates-potent-preclinical 2026-08-17 monthly 0.7 https://rjrindex.com/articles/analysis-of-seasonal-variation-of-sickle-cell-disease-with-crisis-and-associated-complication-in-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bridging-the-cart-gap-epcoritamab-as-a-feasible-option-for-relapsedrefractory-dlbcl-in-cart-inacce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-chimeric-antigen-receptor-t-cell-therapy-outcomes-in-t-cellhistiocyte-rich-large-b-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-study-on-discontinuation-strategies-after-mrd-negativity-in-multiple-myeloma-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chronological-age-predicts-suboptimal-multiple-myeloma-treatment-independent-of-frailty-and-socioenv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phenotype-genotype-characterization-of-inherited-protein-c-deficiency-in-a-qatari-family 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-with-prophylactic-anticoagulation-in-hemolytic-anemias-a-systematic-review 2026-08-17 monthly 0.7 https://rjrindex.com/articles/older-age-and-complex-karyotype-are-the-main-predictors-of-mortality-irrespective-of-allogeneic-tran 2026-08-17 monthly 0.7 https://rjrindex.com/articles/momelotinib-inhibition-of-jakstat-in-a-mouse-jakv617f-myelofibrosis-model-showed-concurrent-activat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blast-clearance-dynamics-and-time-to-response-across-idh1-and-idh2-mutated-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-transcriptomics-reveal-long-non-coding-rna-dysregulation-in-ppp1r15b-eif2a-axis-impairin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/refining-the-prognostic-hierarchy-of-tp53-multihit-alterations-and-isolated-deletion-of-chromosome-5 2026-08-17 monthly 0.7 https://rjrindex.com/articles/complement-inhibition-in-pediatrics-comprehensive-infection-analysis-from-a-large-pediatric-single 2026-08-17 monthly 0.7 https://rjrindex.com/articles/netrin-1-regulates-hematopoietic-stem-cell-function-via-unc5a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/serum-erythropoietin-level-as-a-selective-pressure-in-clonal-hematopoiesis-insights-into-the-mutati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/leveraging-clonal-competition-between-chip-and-malignant-clones-as-a-novel-therapeutic-strategy-in-h 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessing-patient-reported-outcomes-in-phase-3-multiple-myeloma-trials-between-2020-2024-a-systema 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-prognostic-significance-or-lack-of-achieving-marrow-complete-remission-mcr-with-hypomethylat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/remark-a-phase-ii-open-label-multicenter-study-of-orally-administered-romaciclib-rvu120-for-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fapi-petct-as-an-innovative-imaging-tool-for-monitoring-bone-marrow-fibrosis-and-treatment-response 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-landscape-after-anti-bcma-car-t-cell-therapy-in-relapsedrefractory-multiple-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/priming-of-bone-marrow-stromal-cells-with-the-epigenetic-modifier-decitabine-overcomes-stroma-mediat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/indirect-treatment-comparison-of-belantamab-mafodotin-pomalidomide-dexamethasone-versus-comparat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/checkpoint-inhibitors-improve-progression-free-survival-after-autologous-transplant-despite-poorer-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-different-sf3b1-mutations-on-hematopoietic-function-and-erythropoiesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploring-the-disease-impact-of-plasma-metabolites-on-marginal-zone-lymphoma-based-on-mendelian-rand 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-defined-culture-model-for-ex-vivo-expansion-of-primary-aml-cells-preserves-leukemic-stem-cells-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-vitamin-d-deficiency-on-quality-of-life-and-clinical-outcomes-in-patients-with-multiple-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/haploidentical-and-neonatal-combined-transplant-generates-gvl-effect-in-a-murine-model-of-haplo-cord 2026-08-17 monthly 0.7 https://rjrindex.com/articles/diagnosing-mycosis-fungoides-using-ai-powered-histologic-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lived-experience-of-pregnant-patients-with-sickle-cell-disease-a-qualitative-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-hedgehog-signalingkl4-dependent-m2-macrophage-polarization-for-treatment-of-chronic-graft 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-new-validated-staging-system-for-al-amyloidosis-with-stage-iiic-defining-an-ultra-poor-prognostic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-osivelotor-in-participants-with-sickle-cell-disease-in-a-12-week-phase-2-mul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-patterns-of-mutant-asxl1-over-time-and-their-implications-for-treatment-failure-tf-and-bc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-20-patient-safety-and-efficacy-data-from-nexicart-2-the-first-us-trial-of-car-t-in-rr-ligh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-remissions-in-refractory-itp-patients-by-daratumumab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-btki-resistant-cll-using-the-dual-irreversiblereversible-4th-generation-btk-inhibitor-roc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapeutic-resistance-in-aggressive-b-cell-lymphoma-is-overcome-through-the-reciprocal-enhanced-eff 2026-08-17 monthly 0.7 https://rjrindex.com/articles/autophagylysosome-disruption-via-pikfyve-inhibition-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/norad-long-noncoding-rna-a-decoy-for-pumilio-rna-binding-proteins-elevates-fetal-hemoglobin-levels 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-tandem-cd19ror1-car-nk-to-overcome-wnt5a-mediated-apoptotic-resistance-in-chronic-lymphocytic-leu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-a-car-nk-therapy-regulated-by-the-klrc1-locus-as-a-new-platform-for-selective-control 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chronic-stress-promotes-myeloid-bias-in-hematopoiesis-via-the-lactobacillus-ila-foxo1-signaling-axis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/quantitative-morphological-parameters-of-bone-marrow-plasma-cells-are-predictive-of-outcomes-in-plas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prospective-clinical-validation-of-mac-scoring-as-an-affordable-real-time-biomarker-for-hmavenetoc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cpx-351-versus-venetoclax-plus-hypomethylating-agents-in-newly-diagnosed-acute-myeloid-leukemia-a-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/isatuximab-subcutaneous-by-on-body-injector-in-relapsedrefractory-multiple-myeloma-in-the-phase-3-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-treatment-outcomes-of-tp53-mutant-mantle-cell-lymphoma-patients-treated-with-frontline-zanubrut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-demonstrates-durable-clinical-benefits-of-exagamglogene-autotemcel-for-sickle-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-derived-monoclonal-anti-hpa-1a-can-induce-platetet-activation-through-fcyriia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/amx-883-a-potent-and-selective-degrader-of-brd9-drives-differentiation-in-acute-myeloid-leukaemia-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/odronextamab-plus-chemotherapy-in-patients-with-previously-untreated-follicular-lymphoma-first-resu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inferior-survival-in-black-aml-patients-treated-with-intensive-chemotherapy-in-ecog-acrin-clinical-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fixed-duration-versus-continuous-targeted-treatment-for-previously-untreated-chronic-lymphocytic-leu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mosunetuzumab-mosun-or-glofitamab-glofit-in-combination-with-golcadomide-golca-demonstrates-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hemodilution-assessment-for-high-sensitivity-flow-cytometric-measurable-residual-disease-evaluation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-glofitamab-therapy-in-car-t-naive-patients-with-relapsedrefractory-b-cell-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/shorespan-017-phase-3-extension-study-for-safety-of-bomedemstat-in-participants-with-essential-thro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/updates-of-rr-cll-with-prior-exposure-to-brutons-tyrosine-kinase-btk-inhibitor-andor-bcl-2-inhi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acalabrutinib-plus-venetoclax-and-rituximab-in-patients-with-treatment-naive-tn-mantle-cell-lympho 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-myelodysplastic-syndrome-and-chronic-myelomonocytic-leukemia-treated-with-idh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-safety-and-efficacy-of-elvn-001-a-selective-active-site-inhibitor-of-bcrabl1-in-pati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ezh2-and-crebbp-mutation-status-identify-a-subset-of-patients-who-benefit-from-bendamustine-over-ch 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-predictive-model-for-posttransplant-lymphoproliferative-disorder-in-the-letermovir-prophylax 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allo-hct-outcomes-for-aml-patients-with-nup98-rearrangements-a-study-on-behalf-of-the-global-commit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/late-re-expansion-and-high-level-persistence-of-car-t-cells-can-be-driven-by-single-car-t-cell-clon 2026-08-17 monthly 0.7 https://rjrindex.com/articles/neuroinflammation-detected-by-tspo-pet-precedes-dopaminergic-neuronal-loss-in-mnt-following-bcma-dir 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ucd19-car-t-cell-therapy-for-adults-with-b-cell-acute-lymphoblastic-leukemia-in-first-complete-remis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/topical-cyclosporine-vs-tacrolimus-for-ocular-gvhd-prophylaxis-after-outpatient-allogeneic-hematopoi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genomic-profiling-identifies-somatic-alterations-predicting-thromboembolic-risk-in-patients-with-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-pharmacokinetics-with-triazole-prophylaxis-in-patients-with-acute-myeloid-leukemia-in-ind 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatability-with-ibrutinib-plus-venetoclax-in-patients-with-cll-in-the-real-world-the-eric-interna 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhanced-clot-formation-and-altered-platelet-subpopulations-in-mesothelioma-characterized-by-a-high 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hla-alleles-associated-with-inhibitor-development-in-severe-hemophilia-a-analysis-of-the-my-life 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evolution-of-joint-health-and-physical-activity-in-people-with-hemophilia-a-without-factor-viii-inhi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-atlas-of-circulating-immunity-identifies-shared-specific-dlbcl-signatures-predicting-res 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-burden-of-myeloma-treatment-routes-and-locations-on-patients-and-families-insights-from-a-pan-e 2026-08-17 monthly 0.7 https://rjrindex.com/articles/jmjd1c-mediated-epigenetic-control-of-hit-antibody-production 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allogeneic-stem-cell-transplant-for-t-prolymphocytic-leukemia-a-single-center-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/global-sex-and-income-stratified-disparities-in-mortality-due-to-tobacco-associatedleukemia-1990-2 2026-08-17 monthly 0.7 https://rjrindex.com/articles/global-patterns-and-inequities-in-environmental-exposure-associated-leukemia-mortality-by-sex-and-so 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-statin-use-on-cardiovascular-and-hematologic-outcomes-among-patients-with-myeloproliferati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/off-the-shelf-cd117-car-inkt-cells-as-a-safe-and-effective-allogeneic-immunotherapy-targeting-aml-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/computational-profiling-of-predicted-neoantigen-landscape-reveals-differential-immunogenicity-at-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/non-coding-variants-in-uba1-lead-to-vexas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-transcriptomics-of-matched-cerebrospinal-fluid-and-bone-marrow-patient-samples-highlight 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-use-of-talicabtagene-autoleucel-in-rr-b-acute-lymphoblastic-leukemia-is-cost-effective-impro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-neutropenia-on-clinical-outcomes-in-myelodysplastic-syndrome-patients-hospitalized-with-se 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disease-burden-and-treatment-patterns-in-patients-with-previously-treated-primary-immune-thrombocyto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/electronic-heath-record-phenotypes-to-classify-sickle-cell-anemia-versus-other-subtypes-of-sickle-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/polysubstance-use-and-treatment-disparities-among-hospitalized-sickle-cell-disease-patients-a-natio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anti-cd19-chimeric-antigen-receptor-t-cell-therapy-for-transformed-waldenstrom-macroglobulinemialym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tcf-1-overexpression-enhances-cd19car-t-cell-potency-by-attenuating-activation-induced-cell-death 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rapid-jak2-v617f-decline-predicts-response-durability-kinetics-of-jak2-v617f-in-ropeginterferon-alf 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hematopoietic-architecture-drives-biological-and-metabolic-heterogeneity-and-predicts-treatment-free 2026-08-17 monthly 0.7 https://rjrindex.com/articles/remote-therapeutic-monitoring-reduces-hospitalization-due-to-infection-in-patients-being-treated-for 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characteristics-and-prognostic-factors-in-adult-hemophagocytic-lymphohistiocytosis-a-large-single-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transcriptomic-signatures-associated-with-deep-molecular-response-to-ropeginterferon-alfa-2b-in-poly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/use-of-emapalumab-is-associated-with-rapid-and-sustained-benefits-in-primary-hlh-subgroups-includin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/peripheral-immune-checkpoints-predict-prognosis-and-reveal-pd-1tregil-10-crosstalk-in-b-cell-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-dysregulation-in-newly-diagnosed-dlbcl-from-clinical-observations-to-molecular-mechanisms 2026-08-17 monthly 0.7 https://rjrindex.com/articles/asciminib-pediatric-formulation-shows-a-tolerable-safety-profile-in-pediatric-patients-with-chronic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patterns-of-care-and-outcomes-in-patients-with-large-b-cell-lymphoma-not-treated-with-full-dose-anth 2026-08-17 monthly 0.7 https://rjrindex.com/articles/non-gcb-cell-of-origin-leads-to-inferior-outcomes-in-brazilian-diffuse-large-b-cell-lymphoma-patient 2026-08-17 monthly 0.7 https://rjrindex.com/articles/shared-mechanisms-of-resistance-to-zanubrutinib-and-ibrutinib-via-egr1-and-dnmt3a-in-mantle-cell-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/menin-inhibitors-for-npm1-mutated-and-kmt2a-rearranged-relapsedrefractory-acute-myeloid-leukemia-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-hospitalized-sickle-cell-patients-with-palliative-care-consults 2026-08-17 monthly 0.7 https://rjrindex.com/articles/intronic-dna-variants-in-ezh2-and-gata2-predict-treatment-free-remission-in-chronic-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/area-deprivation-index-independently-predicts-outcomes-in-ipss-r-higher-risk-myelodysplastic-syndrom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-with-sustained-progression-free-survival-pfs-benefit-after-subcutaneous-sc-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-antibiotic-linezolid-targets-the-jak2v617f-mutation-in-polycythemia-vera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/analysis-of-the-cost-effectiveness-without-compromising-clinical-outcomes-in-outpatient-cd19-directe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-effectiveness-of-standard-versus-extended-duration-of-anticoagulation-in-children-with-ac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-outcomes-in-patients-with-newly-diagnosed-multiple-myeloma-receiving-ixazomib-as-initial-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessment-of-minimal-residual-disease-with-droplet-digital-polymerase-chain-reaction-for-braf-v600e 2026-08-17 monthly 0.7 https://rjrindex.com/articles/raceethnicity-reporting-and-representation-in-clinical-trials-presented-at-plenary-and-late-breakin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-implications-of-measurable-residual-disease-and-autologous-hematopoietic-stem-cell-transp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/baseline-cd4-count-is-associated-with-early-mortality-in-hiv-associated-lymphoma-a-retrospective-co 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-open-label-study-of-dexamethasone-versus-romiplostim-plus-dexamethasone-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/all-trans-retinoic-acid-mitigates-il-1v-driven-neu1-mediated-megakaryocyte-desialylation-and-dysfunc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-hdm2005-a-ror1-targeted-antibody-drug-conjugate-adc-in-patients-with-relapsed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nqo1-modulates-cd38-surface-expression-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prl-3-enhances-multiple-myeloma-cell-survival-in-acidic-microenvironments-via-metabolic-adaptation-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bone-marrow-spatial-architecture-predicts-response-duration-in-smoldering-multiple-myeloma-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/arginine-deprivation-activates-immunogenic-cell-death-and-enhances-anti-tumor-immunity-in-diffuse-la 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-somatic-hotspot-mutation-of-ddx41-pr525h-elicits-dominant-negative-effects-upon-non-truncatin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/luspatercept-rescues-the-disease-phenotype-of-a-congenital-dyserythropoietic-anemia-type-ii-patient 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-inflammatory-and-immune-recovery-patterns-after-cd19-directed-car-t-cell-therapy-in-sle-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/detection-of-minimal-residual-disease-in-t-cell-acute-lymphoblastic-leukemia-by-16-color-full-spectr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ifn-a-potentiates-daratumumab-response-in-multiple-myeloma-a-commpass-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/connecting-pharmacokinetic-exposure-to-immune-reconstitution-a-pilot-study-in-hla-haploidentical-he 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vd2-unconventional-t-cells-in-the-donor-graft-are-associated-with-improved-overall-survival-after-un 2026-08-17 monthly 0.7 https://rjrindex.com/articles/determining-sensitivity-to-flt3-inhibitors-prior-to-therapy-in-flt3-mutant-acute-myelogenous-leukemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sgr-1505-a-potent-and-selective-malt1-inhibitor-with-preliminary-efficacy-in-btki-exposed-waldenstr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/heterogeneous-tp53-mutation-subtypes-define-prognostic-classification-in-mantle-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-treatment-patterns-and-outcomes-in-older-patients-with-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapy-related-aml-t-aml-on-the-rise-a-national-perspective-on-evolving-trends-treatment-outcom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/application-of-machine-learning-to-identify-risk-factors-for-14-day-emergency-department-return-visi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhanced-homing-and-infiltration-capabilities-of-ci9-cells-improve-treatment-efficacy-for-t-cell-acu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aberrant-circulating-cd4-cd26-t-cells-in-t-cell-rich-b-cell-lymphomas-diagnostic-pitfall-or-bioma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anti-cd94-monoclonal-antibody-dr-01-induced-response-in-a-refractory-primary-cns-t-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/quality-initiative-in-first-line-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma-assessing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-single-center-retrospective-study-of-ixazomib-based-regimens-as-maintenance-therapy-in-newly-diagn 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-survival-predictors-and-up-front-treatment-patterns-in-568-elderly-diffuse-large 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-trial-of-the-ezh2-inhibitor-tazemetostat-combined-with-car-t-cell-therapy-in-b-cell-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allogeneic-hematopoietic-stem-cell-transplantation-in-cr1-and-continuous-chemotherapy-plus-flt3-targ 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-newly-identified-role-for-il-5-in-regulating-cart-associated-toxicity-and-efficacy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hbb-mafk-axis-drives-lipid-metabolism-reprogramming-and-tumor-progression-in-diffuse-large-b-cell-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phenotypic-characterization-of-chimeric-ilt-receptor-natural-killer-cir-nk-cells-targeting-hla-g 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cytokine-release-syndrome-prophylaxis-strategy-with-dipyrone-in-patients-receiving-bispecific-antibo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adherence-to-the-2018-world-cancer-research-fundamerican-institute-for-cancer-research-cancer-preve 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-bispecific-epitope-anti-cd5-nanobody-car-t-cells-for-refractory-or-relapsed-t-cell-malignancie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/experience-of-management-of-patients-with-acute-promyelocytic-leukemia-apl-in-armenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-obinutuzumab-versus-rituximab-based-immunochemotherapy-in-newly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-protein-interactomes-by-the-proximity-network-assay 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-cytokine-release-syndrome-on-survival-following-allogeneic-stem-cell-transplantation-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cta-mediated-up-regulation-of-mhc-reverses-immune-evasion-of-leukemia-stem-cells-in-refractoryrela 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nemtabrutinib-plus-venetoclax-in-relapsed-or-refractory-chronic-lymphocytic-leukemiasmall-lymphocyt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-with-tafasitamab-and-zanubrutinib-in-newly-diagnosed-chronic-lymphocytic-leukemiasm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/next-generation-tumor-specific-anti-cd30-adc-as-a-new-therapy-in-hemato-oncology 2026-08-17 monthly 0.7 https://rjrindex.com/articles/consolidation-with-loncastuximab-tesirine-for-large-b-cell-lymphoma-patients-in-partial-response-aft 2026-08-17 monthly 0.7 https://rjrindex.com/articles/somatic-mutations-in-cancer-related-genes-in-chronic-myeloid-leukemia-patients-receiving-asciminib 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-deconvolution-from-whole-transcriptomic-data-suggests-expansion-of-exhausted-t-cells-and-natu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ze74-0282-is-a-novel-jh2-domain-jak2-inhibitor-with-promising-pre-clinical-activity-in-jak2-v617f-mu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-central-role-of-liver-stifness-measurement-in-adults-with-transfusion-dependent-thalassemia-tdt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-analysis-of-iv-iron-formulations-in-children-results-from-a-large-pediatric-coh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/functional-characterization-of-sec14l4-in-hudep-2-and-mouse-knockout-models-reveals-its-essential-ro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/alternate-dosing-schedules-of-bcma-directed-t-cell-engagers-display-altered-pathways-of-relapse-in-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/quantitative-clinical-pharmacology-analysis-to-support-the-dose-escalation-of-elranatamab-nirogace 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-chromatin-remodeler-hells-regulates-transcription-replication-conflicts-and-genome-integrity-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/numerous-clinically-detected-asciminib-resistant-bcrabl1-mutations-disrupt-allostery-and-confer-cr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/co-mapping-clonal-and-transcriptional-heterogeneity-in-somatic-evolution-via-got-multi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-azacitidine-in-combination-with-chidamide-and-cag-versus-daunorubicin-and-cytarabine-in-n 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-pharmacovigilance-of-bcma-targeted-car-t-therapy-in-refractory-multiplemyeloma-a-compara 2026-08-17 monthly 0.7 https://rjrindex.com/articles/peripheral-residual-disease-activity-assessment-by-maldi-tof-mass-spectrometry-in-patients-with-newl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immunological-and-transcriptomic-analysis-of-febrile-neutropenia-in-hematological-malignancies-socs 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-tlr4-hsp70-efferocytic-program-in-thymic-macrophages-sustains-thymic-homeostasis-and-t-cell-output 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-combination-immunotherapy-of-eltrombopag-atg-and-cyclosporine-in-aplastic-anaemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nationwide-real-world-outcomes-of-poems-syndrome-long-term-impact-of-asct-maintenance-therapy-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/machine-learning-uncovers-prognostically-distinct-myeloma-cast-nephropathy-phenotypes-not-captured-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-analysis-of-orelabrutinib-combined-with-obinutuzumab-in-the-treatment-of-marginal-zone-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/data-validation-and-quality-framework-for-building-a-european-multimodal-real-world-dataset-for-clin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-preliminary-efficacy-of-anti-cd19-car-t-cells-zorpocabtagene-autoleucel-in-systemic-autoi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-greatwall-kinase-inhibition-as-a-potential-therapeutic-strategy-in-cll-and-dlbcl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-pivotal-phase-3-study-to-investigate-efficacy-safety-and-tolerability-of-mavo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sickle-cell-disease-presenting-with-chronic-lower-extremity-ulcers 2026-08-17 monthly 0.7 https://rjrindex.com/articles/idh1-mutation-predicts-response-and-survival-in-treatment-naive-acute-myeloid-leukemia-patients-rece 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-case-report-of-ruxolitinib-reversing-myelofibrosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genetic-evolution-of-waldenstrom-macroglobulinemia-across-disease-stages 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pim1-mutation-drives-anxa2-membrane-relocalization-and-promotes-lymphomagenesis-through-pi3kaktmto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/electrocardiographic-abnormalities-and-qtc-prolongation-in-sickle-cell-disease-insights-from-the-cs 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-safety-and-efficacy-of-iptacopan-in-patients-with-paroxysmal-nocturnal-hemoglobinuria-4 2026-08-17 monthly 0.7 https://rjrindex.com/articles/validation-of-the-artificial-intelligence-prediction-of-acute-leukemia-tool-in-a-latin-american-retr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-pomalidomide-containing-induction-chemotherapy-on-hematopoietic-stem-cell-mobilization-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/flt3-ligand-facilitates-long-term-ex-vivo-expansion-of-human-hematopoietic-stem-cells-by-maintaining 2026-08-17 monthly 0.7 https://rjrindex.com/articles/paquinimod-regulate-megakaryocyte-function-by-restoring-mitochondrial-oxidative-phosphorylation-in-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cxcr5pd-1-circulating-t-follicular-helper-cells-identify-vaccine-readiness-in-pediatric-allogeneic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thymic-dysfunction-promotes-the-emergence-of-pathogenic-peripheral-cd4cd8-t-cells-and-induces-tiss 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd84-cd3-bispecific-antibody-achieves-potent-anti-leukemic-activity-with-favorable-safety-profile-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tfeb-regulates-cd8-t-cell-proliferation-in-vivo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characteristics-of-the-spatio-temporal-distributions-of-chimeric-antigen-receptor-t-cells-based-on-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-intercontinental-external-quality-assessment-program-for-flow-cytometric-measurable-residual 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-transplant-cyclophosphamide-vs-tacrolimusmethotrexate-improved-grfs-reduced-nrm-and-less-se 2026-08-17 monthly 0.7 https://rjrindex.com/articles/frontline-ponatinib-vs-imatinib-in-newly-diagnosed-philadelphiapositive-all-systematic-review-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beyond-the-genome-an-integrated-multi-omics-approach-to-uncover-histone-ptm-driven-metabolic-and-pr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hematologic-malignancies-in-pediatric-patients-with-runx1-familial-platelet-disorder-with-associated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/skp2cks1b-as-a-rational-drug-target-in-1q21-amplified-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fusion-specific-regulation-of-polyamine-synthesis-sensitizes-to-bcl-xl-inhibition-in-tcf3pbx1-b-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-of-obstructive-sleep-apnea-with-readmission-and-healthcare-utilization-in-adults-with-si 2026-08-17 monthly 0.7 https://rjrindex.com/articles/xs003-an-amorphous-re-formulation-of-nilotinib-demonstrates-improved-dose-linearity-and-minimal-fo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-carfilzomib-based-combinations-in-relapsedrefractory-multiple-myeloma-patien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/direct-oral-anticoagulation-management-to-address-primary-and-secondary-adherence-in-atrial-fibrilla 2026-08-17 monthly 0.7 https://rjrindex.com/articles/subgroup-analysis-based-on-prior-treatment-from-the-phase-3-allele-study-of-tabelecleucel-for-epstei 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ibrutinib-in-combination-with-rituximab-methotrexate-mtx-vincristine-and-procarbazine-r-mpvi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-midline-versus-peripheral-intravenous-catheters-a-systematic-review-and-me 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mpn-with-multiple-driver-clones-show-distinct-patterns-of-therapy-response-and-progression-mpn-do 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clia-plus-venetoclax-for-aml-feasibility-and-efficacy-in-a-hybrid-community-setting 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acute-lymphoid-leukemia-burden-attributable-to-occupational-benzene-exposure-from-1990-2021-global 2026-08-17 monthly 0.7 https://rjrindex.com/articles/teclistamy-emn40-a-phase-2-trial-of-teclistamab-in-patients-with-previously-treated-light-chain 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hemoglobin-sc-disease-clinical-analysis-from-the-georgia-comprehensive-sickle-cell-center-at-grady 2026-08-17 monthly 0.7 https://rjrindex.com/articles/btk-regulates-ezh2-stability-in-myeloid-leukemia-associated-with-down-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thirty-day-readmission-in-patients-with-brain-cancer-and-venous-thromboembolism-a-nationwide-analys 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-talquetamab-in-patients-with-relapsed-and-refractory-multiple-myeloma-rrmm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-marginalization-on-outcomes-in-patients-with-hodgkin-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/atra-and-ato-can-induce-remission-in-npm1-mutated-aml-first-clinical-report-of-a-chemo-free-strateg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-assessment-of-phenotype-and-receptor-profile-of-in-vitro-expanded-healthy-natural-killer-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dose-modifications-of-mezigdomide-when-coadministered-with-cyp3a4-inhibitors-for-patients-with-relap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prevalence-treatment-patterns-and-complications-of-sickle-cell-disease-in-insured-us-populations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/glucocorticoid-metabolizing-enzymes-predict-initial-glucocorticoid-sensitivity-in-childhood-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-with-ponatinib-in-patients-with-relapsedrefractory-philadelphia-chromosome-positive-acute 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dissecting-the-whole-trajectory-of-aid-induced-genomic-instability-from-mutational-activity-to-chrom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-combined-with-three-day-multi-frequency-decitabine-vincristine-and-dexamethasone-vdvd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-combined-with-three-day-multi-frequency-decitabine-dec3-ven-vs-venetoclax-combined-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-and-azacytidine-in-childhood-primary-advanced-myelodysplastic-syndromes-refractoryrelap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/maximizing-the-potential-of-optical-genome-mapping-through-comprehensive-automated-data-analysis-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treosulfan-based-conditioning-in-allogeneic-hematopoietic-stem-cell-transplantation-for-lymphoid-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-2-bellwave-003-cohort-f-updated-clinical-outcomes-of-nemtabrutinib-in-participants-with-relap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/changes-in-neutrophil-to-lymphocyte-ratio-nlr-in-patients-with-polycythemia-vera-treated-with-ruxo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allogeneic-hematopoietic-stem-cell-transplantation-for-transfusion-dependent-pyruvate-kinase-deficie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/favorable-impact-of-patients-selection-on-outcome-of-relapsedrefractory-multiple-myeloma-treated-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-frequency-monitoring-of-clonal-dynamics-in-mpn-using-saliva-and-peripheral-blood-during-interfe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-1b-study-of-hc-7366-alone-and-in-combination-with-venetoclax-and-azacitidine-in-relapsedrefra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-study-of-population-pharmacokinetic-guided-pdvwffviii-11-prophylaxis-in-people-with-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/daratumumab-can-lead-to-long-lasting-remissions-in-patients-with-refractory-immune-thrombocytopenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-acalabrutinib-in-treatment-naive-mantle-cell-lymphoma-a-systematic-review-and-meta-anal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hesperadin-an-aurora-b-kinase-inhibitor-synergizes-with-chidamide-to-suppress-t-cell-acute-lymphob 2026-08-17 monthly 0.7 https://rjrindex.com/articles/from-mechanistic-synergy-to-clinical-breakthrough-updated-results-from-a-phase-ii-trial-of-hd-mtx 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-integrative-prognostic-model-for-transplant-outcomes-in-myelofibrosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dose-dense-rituximab-for-high-risk-children-and-adolescents-with-newly-diagnosed-acute-immune-thromb 2026-08-17 monthly 0.7 https://rjrindex.com/articles/response-adapted-treatment-with-mosunetuzumab-with-or-without-obinutuzumab-and-polatuzumab-vedotin-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/revumenib-in-combination-with-intensive-induction-and-consolidation-for-newly-diagnosed-patients-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-relevance-of-multiparameter-flow-cytometry-based-mrd-assessment-in-patients-with-flt3-itd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-experience-of-patient-outcomes-in-a-dedicated-clonal-hematopoiesis-hematology-clinic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/refining-diffuse-large-b-cell-lymphoma-subtyping-using-lymphly-an-evidence-based-classifier 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sutacimig-a-novel-bispecific-antibody-for-prophylactic-treatment-of-glanzmann-thrombasthenia-analy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-incidence-and-management-of-non-icans-neurologic-events-following-ciltacabtagene-autoleuc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-putative-cell-of-origin-on-cd19car-t-outcomes-in-patients-with-large-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/correlation-between-interleukin-il-8-and-tumor-necrosis-factor-tnf-alpha-levels-and-overall-surv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incb160058-selectively-targets-jak2v617f-driven-hematopoiesis-in-diverse-and-drug-resistant-models-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/somatic-mutations-at-diagnosis-in-patients-with-chronic-phase-cml-receiving-frontline-imatinib-are-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allogeneic-hematopoietic-cell-transplantation-in-tp53-mutated-acute-myeloid-leukemia-patients-with-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-following-disease-progression-after-epcoritamab-or-glofitamab-in-the-real-world-outcomes-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cll-1-chimeric-antigen-receptor-t-cells-for-the-treatment-of-acute-myeloid-leukemia-a-phase-1-clini 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vitamin-d-and-other-micronutrients-influence-prognosis-of-patients-with-non-hodgkin-lymphoma-nhl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interim-analysis-of-the-phase-ii-study-of-glofitamab-lenaliomide-and-venetoclax-glove-in-untreate 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-ici-associated-hlh-reveals-early-mortality-despite-standard-interventions 2026-08-17 monthly 0.7 https://rjrindex.com/articles/standard-tyrosine-kinase-inhibitor-dose-versus-dose-de-escalation-prior-to-treatment-free-remission 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-dimorphism-at-the-hla-b-leader-and-molecular-hla-compatibility-impact-on-haplo-hsct-experience 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinically-meaningful-improvement-of-the-modified-lee-symptom-score-in-patients-treated-with-belumos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-pilot-study-of-low-dose-sirolimus-to-increase-hematopoietic-function-in-patients-with-runx1-famili 2026-08-17 monthly 0.7 https://rjrindex.com/articles/demographic-and-clinical-risk-factors-for-renal-complications-and-associated-non-relapse-mortality-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ifn-gh-induced-cd4-cadm1-t-cells-emerged-as-malignancy-progressive-biomarkers-in-ebv-nkt-lymphopro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-angiotensin-converting-enzyme-inhibitors-aceis-or-angiotensin-ii-receptor-blockers-arbs 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-remission-immunotherapy-with-vididencel-for-a-measurable-residual-disease-defined-high-risk-sub 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-gb3226-a-novel-dual-inhibitor-of-enl-yeats-and-flt3-in-patients-with-relapsed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vte-management-in-primary-central-nervous-system-neoplasms-a-retrospective-cohort-study-in-a-canad 2026-08-17 monthly 0.7 https://rjrindex.com/articles/undiagnosed-patent-foramen-ovale-with-bi-atrial-thrombus-in-transit-a-case-of-pulmonary-embolism-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rising-mortality-trends-in-elderly-multiple-myeloma-patients-with-hypertension-a-cdc-wonder-databas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-frailty-on-real-world-outcomes-for-multiple-myeloma-patients-in-england-a-cohort-stu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enumeration-of-plasma-cells-in-the-bone-marrow-of-persons-with-multiple-myeloma-correlation-between 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinicopathological-characteristics-and-survival-outcomes-in-adults-with-acute-megakaryoblastic-leuk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-7-day-versus-standard-venetoclax-exposure-in-combination-with-azacitidine-in-frontline-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-profile-linked-to-resistance-to-hypomethilating-agents-plus-venetoclax-does-not-predict-ou 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dissecting-the-heterogeneity-of-ighv-mutated-cll-an-eric-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-center-single-arm-clinical-trial-of-zanubrutinib-monotherapy-and-zfcg-combine 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hypomethylating-agent-with-venetoclax-versus-hypomethylating-agent-alone-in-frontline-management-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-cytarabine-consolidation-dosing-in-older-adult-patients-with-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/organ-based-classification-and-risk-stratified-outcomes-in-568-east-asian-patients-with-chronic-acti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-tracing-of-myeloid-leukemia-evolution-in-down-syndrome-reveals-a-latent-progenitor-bridg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mis-splicing-of-mdm4-activates-trp53-and-impairs-hspc-growth-in-a-mouse-model-of-myelodysplastic-syn 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clone-specific-epigenetic-regulatory-mechanisms-in-asxl1-mutant-chronic-myelomonocytic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/double-trouble-the-first-reported-case-of-evans-syndrome-following-rsv-vaccination 2026-08-17 monthly 0.7 https://rjrindex.com/articles/refined-elderly-comorbidity-index-is-highly-predictive-of-post-transplant-survival-in-older-adults-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/current-clinical-concerns-for-patients-with-hereditary-hemochromatosis-a-delphi-consensus-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/realworld-effectiveness-and-patient-centered-outcomes-of-fixedduration-vs-continuous-firstline-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-and-genomic-impact-of-tp53-and-bcl2-co-alterations-in-diffuse-large-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/availability-of-blood-products-and-transfusion-practices-in-sub-saharan-africa-for-the-management-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-23-multicenter-randomized-open-label-study-evaluating-the-efficacy-and-safety-of-etentam 2026-08-17 monthly 0.7 https://rjrindex.com/articles/emergency-myelopoiesis-and-monocyte-reprogramming-underlie-immune-dysregulation-in-lymphoma-associat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-line-romiplostim-combined-with-immunosuppressive-therapy-for-severe-aplastic-anemia-a-prospec 2026-08-17 monthly 0.7 https://rjrindex.com/articles/msc-regulates-the-function-of-neutrophils-through-mitochondrial-transmission-to-treat-early-pulmonar 2026-08-17 monthly 0.7 https://rjrindex.com/articles/diagnostic-disparities-in-sickle-cell-disease-rates-and-implications 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thromboembolic-and-cardiovascular-events-after-car-t-cell-therapy-in-multiple-myeloma-a-propensity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/initiation-of-ace-inhibitors-or-beta-blockers-during-frontline-therapy-for-pediatric-acute-myeloid-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/regulatory-network-analysis-identifies-changes-in-ahr-tfap4-and-ap-1-transcription-factors-as-top 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-interhospital-transfer-on-inpatient-outcomes-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/central-nervous-system-disease-status-significantly-impacts-survival-in-pediatric-acute-myeloid-leuk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evidence-for-pre-existing-myeloma-cells-with-a-gene-expression-pattern-associated-with-resistance-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/upstream-integration-of-implementation-planning-in-clinical-trials-through-the-blood-and-marrow-tran 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrating-patient-and-clinician-perspectives-to-advance-rr-cll-care-results-of-a-multi-pronged-g 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deepening-responses-and-mrd-conversion-in-a-phase-ii-fixed-duration-consolidation-trial-of-elranatam 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-level-meta-analysis-of-minimal-residual-disease-and-progression-free-survival-in-follicular-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-preliminary-study-on-the-roles-and-mechanisms-of-il-17a-monoclonal-antibody-in-chronic-graft-versu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tp53-ezh2-or-runx1-mutations-predict-poor-outcomes-in-eln-2022-adverse-risk-group-of-adult-aml-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-recurrent-aml-associated-cbfbd87gdsy-mutation-has-hypomorphic-function-and-is-mechanistically-di 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sex-and-ethnicity-related-differences-in-primary-central-nervous-system-lymphoma-based-on-the-seer-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-whole-blood-amustaline-pathogen-inactivation-on-plasma-coagulation-factor-activity-mechan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tp53-mutated-acute-myeloid-leukemia-through-a-single-cell-lens 2026-08-17 monthly 0.7 https://rjrindex.com/articles/economic-and-clinical-impact-of-emicizumab-in-people-with-moderate-and-severe-hemophilia-a-in-the-us 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adjudicated-clinical-outcomes-of-plasma-microbial-cell-free-dna-surveillance-in-neutropenic-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/socio-clinical-determinants-and-demographic-disparities-of-survival-in-splenic-marginal-zone-lymphom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nsd2-expression-remodels-dna-methylation-creating-a-targetable-epigenetic-dependency-in-t414-mul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improvement-in-sickle-cell-disease-care-metrics-regular-scheduled-hematology-provider-visits-and-tr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-selective-jak1-inhibitor-upadacitinib-restores-impaired-neutrophil-chemotaxis-in-the-proplatelet 2026-08-17 monthly 0.7 https://rjrindex.com/articles/garplrrc32-defines-the-erythroid-megakaryocyte-fate-decision-and-enables-v-globin-program-activatio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-results-of-nonremission-relapsedrefractory-dlbcl-with-car-t-cell-cocktail-thera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/feasibility-of-characterizing-von-willebrand-disease-using-high-throughput-affinity-based-proteomics 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-dementia-on-in-hospital-outcomes-in-hematopoietic-stem-cell-transplant-hsct-recipients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/eltrombopag-plus-g-csf-for-peripheral-blood-stem-cell-mobilization-final-analysis-of-a-single-arm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-single-arm-open-label-multi-center-phase-1b2-study-to-evaluate-the-safety-efficacy-and-cellu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/uncovering-molecular-trajectories-in-follicular-lymphoma-using-hidden-markov-models-of-ctdna-dynamic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-role-of-rhoa-in-diffuse-large-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/radiomic-features-from-pet-ct-enable-diagnostic-and-prognostic-stratification-in-peripheral-t-cell-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-with-sirolimus-for-refractoryrelapsed-primary-or-secondary-warm-autoimmune-hemolytic-anem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/use-of-bispecific-antibody-talquetamab-before-leukapheresis-may-lead-to-out-of-specification-ciltaca 2026-08-17 monthly 0.7 https://rjrindex.com/articles/slm124-a-first-in-class-anti-cd84-antibody-drug-conjugate-demonstrates-potent-anti-tumor-activity-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/from-1968-to-2050-trends-and-forecasts-of-acute-lymphoblastic-leukemia-mortality-among-older-adults 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myeloproliferative-neoplasms-unclassifiable-mpn-u-a-carefully-curated-series-of-30-mayo-clinic-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/feasibility-and-safety-of-accelerated-glofitamab-step-up-in-rapidly-progressive-relapsedrefractory 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lymphoma-are-the-most-frequent-secondary-hematologic-malignancies-following-solid-tumors-a-large-co 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-survey-of-triplet-versus-quadruplet-regimen-preferences-in-transplant-ineligible-tie-or 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ocular-adnexal-non-hodgkin-lymphoma-among-hispanic-latino-population-18-years-of-experience 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inflammatory-signaling-selectively-disrupts-gata-factor-regulated-networks-governing-erythroid-diffe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-low-intensity-aml-therapy-based-on-treatment-facility 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-phosphorylation-by-aurkb-regulates-transcriptional-functions-of-klf1-during-erythropoiesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-current-diagnostic-workup-for-pediatric-severe-aplastic-anemia-low-incidence-of-crypt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-diffuse-non-hodgkin-lymphoma-related-mortality-among-us-elderly-adults 2026-08-17 monthly 0.7 https://rjrindex.com/articles/downregulation-of-tank-gene-affects-erythroid-differentiation-in-pnh-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-translation-of-single-cell-measurable-residual-disease-scmrd-assay-in-real-world-acute-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cmml2aml-machine-learning-discovery-of-co-mutations-predictive-of-blast-transformation-in-chronic-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clonal-evolution-and-risk-assessment-in-myelodysplastic-syndromes-mds-a-prospective-study-of-dyna 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immunosuppressive-t-cell-landscape-in-myelodysplastic-neoplasms-with-tp53-mutations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/non-infectious-fever-predicts-poor-survival-in-azacitidine-treated-high-risk-but-not-low-risk-myel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-does-not-predict-solid-tumor-malignancy-in-people-living-with-hiv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chronic-pulmonary-lps-exposure-in-cystic-fibrosis-drives-maladaptive-pro-inflammatory-hematopoietic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/butyrate-ameliorates-tet2-deficient-clonal-hematopoiesis-phenotypes-driven-by-high-b12-induced-gut-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-clinical-outcomes-in-patients-with-essential-thrombocythemia-treat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/neutrophil-extracellular-traps-drive-myeloproliferation-and-immune-dysfunction-in-chronic-myelomonoc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/detection-of-mutation-in-cell-free-dna-predicts-poor-outcomes-in-adult-patients-with-langerhans-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-iii-clinical-trial-of-romaciclib-rvu120-as-monotherapy-and-in-combination-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-practices-and-outcomes-of-advanced-stage-classical-hodgkin-lymphoma-in-india-an-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/frontline-experience-with-second-generation-covalent-bruton-tyrosine-kinase-inhibitors-for-mantle-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-restoration-in-long-term-myeloma-survival-revealed-by-single-cell-rna-sequencing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/talquetamab-alters-t-cell-transcriptome-in-presence-of-gprc5d-on-mm-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-transcriptomics-reveals-pathogenic-interactions-between-clonal-plasma-cells-and-monocyte 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multiomic-evidence-of-coordinated-complex-rearrangements-enhancer-hijacking-and-epigenomic-signatu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-eltrombopag-combined-with-immunosuppressive-therapy-in-adults-with-severe-aplastic-anemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tissue-specific-requirement-for-the-inv16-oncogene-cbfbmyh11-implies-unique-leukemia-survival-me 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-belumosudil-for-chronic-gvhd-by-line-of-treatment-analysis-of-academic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/maturing-progenitor-like-immunophenotypic-cluster-and-megakaryocytic-repopulating-ability-predict-me 2026-08-17 monthly 0.7 https://rjrindex.com/articles/activation-effects-of-chidamide-on-bet-signaling-pathways-and-the-mechanism-of-synergistic-effect-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/influence-of-cardiovascular-co-morbidities-on-the-in-hospital-mortality-among-patients-with-sickle-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-ikzf1-deletion-subtypes-in-ph-negative-bcp-all-biallelic-null-deletion-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ifn-gh-driven-hepatic-injury-exacerbates-mortality-in-nkt-cell-lymphoma-associated-hemophagocytic-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-hemolysis-and-raas-osivelotor-and-losartan-ameliorate-sickle-cell-renal-pathology 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mendelian-randomization-reveals-the-causative-role-of-genetically-predicted-viral-infection-in-pan-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exercise-capacity-and-oxygen-saturation-on-six-minute-walk-testing-relate-to-markers-of-organ-dysfun 2026-08-17 monthly 0.7 https://rjrindex.com/articles/poor-nutritional-intake-prior-to-allogeneic-hematopoietic-cell-transplantation-is-associated-with-hi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/azer-cel-an-allogeneic-allo-cd19-car-t-in-combination-with-low-dose-interleukin-2-il-2-demonst 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gene-modified-ipsc-derived-mscs-convert-immunosuppressive-tumor-microenvironments-tmes-into-distin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dietary-saturated-fatty-acid-composition-alters-the-platelet-lipid-profile-and-promotes-platelet-hyp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/differential-impacts-of-lama4-deficient-microenvironment-on-fitness-of-bcrabl1-expressing-cells-du 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-of-patients-with-myelodysplastic-syndrome-by-line-of-ther 2026-08-17 monthly 0.7 https://rjrindex.com/articles/piezo1-activation-controls-erythropoiesis-through-calpain-dependent-degradation-of-hsp70 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrative-genomic-single-cell-and-functional-profiling-uncovers-immune-consequences-of-the-cd48 2026-08-17 monthly 0.7 https://rjrindex.com/articles/analysis-of-cd8-cytotoxic-t-cells-in-patients-with-myelodysplastic-syndrome-mds-and-t-cell-large-g 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-subset-clonality-profiling-in-aplastic-anemia-a-highly-sensitive-flow-cytometry-approach-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-results-of-aponerminapo-improving-teclistamab-tectalquetamab-tal-in-patients-pts-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-molecular-profiling-of-sf3b1-mutated-myelodysplastic-syndrome-mds-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/kir3dl2-directed-car-t-cell-therapy-for-t-cell-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tumor-intrinsic-mechanisms-leading-to-cevostamab-resistance-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-novel-driver-genes-of-multiple-myeloma-through-genome-scale-crispr-activation-st 2026-08-17 monthly 0.7 https://rjrindex.com/articles/intravital-imaging-of-the-spatiotemporal-dynamics-of-fibrinolysis-in-a-murine-model-of-vascular-inju 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rethinking-ferritin-reference-ranges-for-diagnosing-iron-deficiency-at-denver-health 2026-08-17 monthly 0.7 https://rjrindex.com/articles/propensity-score-matched-analysis-supports-the-survival-benefits-of-combination-chimeric-antigen-rec 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anti-cd19-car-t-cells-therapy-can-overcome-the-prognostic-impact-of-cd5-positivity-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/analysis-of-the-role-of-baseline-petct-in-a-prospective-study-of-unselected-patients-the-uk-mcl-bi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-prospective-study-reveals-feasibility-and-merits-of-drug-profiling-guided-precision-therapy-for-ch 2026-08-17 monthly 0.7 https://rjrindex.com/articles/community-health-worker-contacts-for-high-utilizer-vs-other-sickle-cell-patients-in-an-adult-sickle 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-molecular-genetic-and-cytogenetic-alterations-in-newly-diagnosed-acute-myeloid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/car-t-cell-therapy-in-tp53-mutated-cns-lymphoma-overcoming-a-high-risk-genetic-barrier 2026-08-17 monthly 0.7 https://rjrindex.com/articles/kte-x19-in-relapsed-or-refractory-adult-b-cell-acute-lymphoblastic-leukemia-in-the-chinese-populatio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/use-and-outcomes-following-blinatumomab-rechallenge-in-adolescents-and-young-adults-aya-and-adults 2026-08-17 monthly 0.7 https://rjrindex.com/articles/biphasic-effects-of-cyclophosphamide-on-l-asparaginase-hypersensitivity-and-resistance-in-mice 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dysregulation-of-nf-kb-and-p73-signal-axes-in-chronic-lymphocytic-leukemia-with-gain-of-function-mut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-demographic-disparities-in-myelodysplastic-syndrome-associated-mortality-in-acut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-center-retrospective-analysis-of-maribavir-in-the-treatment-of-refractory-and-drug-intolerant 2026-08-17 monthly 0.7 https://rjrindex.com/articles/residual-mutations-in-epigenetic-modifiers-are-associated-with-poor-prognosis-and-high-relapse-rate 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-impact-of-anti-cd38-based-quadruplet-regimens-in-transplant-ineligible-newly-diagnosed-mult 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-zanubrutinib-combined-with-chemotherapy-in-the-treatment-of-relapsedrefracto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-ib-study-to-assess-the-efficacy-and-safety-of-epcoritamab-in-relapsed-or-refractory-post-trans 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distance-to-specialized-care-predicts-emergency-department-pain-infusion-clinic-and-inpatient-util 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-board-exam-outcomes-a-structured-exam-preparation-curriculum-for-hematologyoncology-fel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/self-reported-prophylaxis-treatment-experience-among-persons-living-with-hemophilia-a-in-the-us-a-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/basal-and-stimulated-intra-rbc-and-exported-atp-and-rbc-adhesivity-ex-vivo-in-children-with-sickle-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-hla-loss-of-heterozygosity-on-outcome-after-haploidentical-hematopoietic-stem-cell-tra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-l-glutamine-in-texas-medicaid-patients-with-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/liver-disease-in-shwachman-diamond-syndrome-a-report-from-the-shwachman-diamond-syndrome-registry 2026-08-17 monthly 0.7 https://rjrindex.com/articles/granulocyte-maturation-and-splicing-defects-in-ddx41-mutated-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-14650-patients-with-mycosis-fungoidessezary-syndrome-from-academic-and-com 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-zanubrutinib-plus-bendamustine-rituximab-in-newly-diagnosed-mantle-cell-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/increased-incidence-of-secondary-malignancies-after-autologous-stem-cell-transplantation-in-follicul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/plasma-proteomic-profiles-predict-future-non-hodgkin-lymphoma-in-healthy-adults 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-and-validation-of-automated-multiplexed-immunofluorescence-for-clinical-lymphoma-diagnose 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dissecting-the-biology-of-hairy-cell-leukemia-variant-insights-from-whole-exome-and-rna-sequencing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pharmacokinetics-pharmacodynamics-and-biomarkers-of-lbl-034-a-gprc5d-targeted-t-cell-engager-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-real-world-analysis-on-the-impact-of-glp-1-receptor-agonist-use-on-all-cause-mortality-and-hematol 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-disparities-in-acute-leukemia-among-patients-with-hiv-a-nationwide-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-time-spent-at-home-for-patients-with-secondary-acute-myeloid-leukemia-treated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-throughput-single-cell-methylation-resolves-epigenetic-states-in-hematopoietic-differentiation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/social-determinants-outweigh-geographic-barriers-in-acute-myeloid-leukemia-survival-insights-from-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-overall-survival-in-mds-from-2000-2022-have-therapeutic-advances-made-a-difference 2026-08-17 monthly 0.7 https://rjrindex.com/articles/t-cell-receptor-costimulation-blockade-effectively-prevents-acute-graft-versus-host-disease-without 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-predictive-framework-leveraging-integration-site-profiling-to-stratify-car-t-response-in-relapsed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-multi-omics-uncovers-transposable-element-regulation-in-hematopoietic-stem-and-progenito 2026-08-17 monthly 0.7 https://rjrindex.com/articles/peripheral-blood-based-single-cell-and-genomic-profiling-of-hematopoietic-stem-and-progenitor-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-ii-trial-of-vdj-001-a-high-affinity-il-6r-antagonist-antibody-for-the-treatmen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reduced-dose-whole-brain-radiotherapy-is-an-effective-consolidation-strategy-for-parenchymal-only-se 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-prognostic-value-of-jak2v617f-burden-for-discontinuation-of-interferon-a2-in-patients-with-myelo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/its-not-yet-time-to-abandon-ruxolitinib-in-anemic-myelofibrosis-predictive-factors-of-erythroid-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multiple-asxl1-mutations-and-g646fs-alterations-confer-increased-risk-of-leukemic-transformation-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/celfib-ai-a-machine-learning-model-to-predict-bone-marrow-fibrosis-and-cellularity-from-complete-bl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/donor-derived-car-t-cells-co-infused-with-the-allogenic-graft-on-the-platform-of-t-cell-depletion-or 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-with-the-use-of-gemtuzumab-ozogamycin-in-patients-with-acute-myeloid-leukemia-rece 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-baseline-transcriptomic-signature-predictive-of-clinical-response-to-menin-inhibitors-in-aml-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/international-prospective-study-comparing-nilotinib-versus-imatinib-with-early-switch-to-nilotinib 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-t-cellhistocyte-rich-large-b-cell-lymphoma-thrlbcl-an-international-leomer-and-nihi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reversal-of-declining-cardiac-mortality-trends-in-hemolytic-anemia-national-evidence-from-1999-to-2 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ivosidenib-with-or-without-hypomethylating-agent-in-idh1-mutated-aml-real-world-evidence-to-inform 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sepsis-in-acute-myeloid-leukemia-aml-patients-a-407095-patient-national-inpatient-sample-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-mortality-due-to-acute-myeloid-leukemia-and-sepsis-in-us-adults-aged-25-years 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-vwf-mutation-associated-with-macrothrombocytopenia-cytoskeletal-defects-and-distinct-funct 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aml-maturation-stages-associate-with-disease-permissive-and-immunosuppressive-effects-in-newly-diagn 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-enhances-t-cell-fitness-and-car-t-cell-manufacturing-potential-in-chronic-lymphocytic-leu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/emergency-department-presentation-is-an-independent-driver-of-mortality-complications-and-disparit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-due-to-hematological-malignancies-and-aplastic-anemia-in-us-adults-from-1999-202 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-insights-into-diffuse-large-b-cell-lymphoma-from-ehr-derived-data-in-germany-and-the-unit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/engineered-il7il15-secreting-ipsc-derived-mesenchymal-stromal-cells-reprogram-the-immunosuppressive 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identifying-splice-variants-of-cell-surface-proteins-for-chimeric-antigen-receptor-t-cell-therapy-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lutetium-177-dotatate-prrt-in-gep-nets-hematologic-toxicity-trends-recovery-profiles-and-disconti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-npm1-mutated-amls-in-first-hematological-relapse-and-prognostic-value-of-mrd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/baseline-t-cell-fitness-and-subtype-specific-cd19-loss-as-drivers-of-blinatumomab-resistance-in-b-al 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aml1eto-upregulates-fatty-acid-metabolism-to-induce-venetoclax-resistance-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/direct-thrombin-inhibition-by-paraprotein-in-multiple-myeloma-a-rare-mechanism-of-paraprotein-media 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-with-an-eya2-inhibitor-prolongs-survival-of-six1-expressing-murine-t-cell-leukemias 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-maternal-fetal-transfer-of-liposomal-daunorubicin-and-cytarabine-in-an-ex-vivo-hum 2026-08-17 monthly 0.7 https://rjrindex.com/articles/minimal-residual-disease-guided-venetoclax-plus-rituximab-for-patients-with-previously-untreated-chr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-an-individualized-prognostic-model-based-on-gut-microbiota-related-genes-in-pediatric 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unusual-laboratory-manifestations-of-fibrinogen-gh-chain-pala108gly-genetic-variant-a-case-report 2026-08-17 monthly 0.7 https://rjrindex.com/articles/determinants-of-survival-in-t-cell-large-granular-lymphocytic-leukemia-t-lgl-analysis-of-a-real-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/loss-of-endothelial-mir-126-drives-age-related-reduction-of-hematopoietic-activity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-inequities-in-newly-diagnosed-diffuse-large-b-cell-lymphoma-dlbcl-comparing-polatuzumab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-pilot-trial-of-olutasidenib-maintenance-post-allogeneic-hematopoietic-cell-transp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mortality-in-immune-ttp-remains-unpredictable-shortcomings-of-prediction-models-despite-machine-lea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-outcomes-and-economic-burden-of-cytokine-release-syndrome-and-immune-effector-cell-associ 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-immunoglobulin-supplementation-on-infection-rates-in-myeloma-patients-receiving-novel-immu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-risk-and-racial-disparities-in-second-primary-malignancies-among-diffuse-large-b-cell-lymp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-relapsedrefractory-aggressive-b-cell-lymphoma-receiving-bispecific-antibo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploratory-risk-score-incorporating-donor-type-mf-hct-high-risk-mutations-and-day-100-chimerism-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/csf1r-csf1-axis-blockade-with-axatilimab-effectively-targets-leukemia-stem-cells-and-monocytes-in-am 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-mitoxantrone-hydrochloride-liposome-combined-with-pegaspargase-in-the-treatme 2026-08-17 monthly 0.7 https://rjrindex.com/articles/analysis-of-cardiovascular-risk-factors-in-a-cohort-of-patients-with-itp-in-a-tertiary-care-center 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-refractory-thrombocytopenia-a-retrospective-overview-of-seer-database 2026-08-17 monthly 0.7 https://rjrindex.com/articles/histone-acetyltransferase-p300cbp-as-a-therapeutic-target-to-ameliorate-gvhd-induced-inflammatory-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cytokine-signatures-in-immune-thrombocytopenia-across-clinical-stages 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mpn-myeloproliferative-neoplasm-journal-a-platform-developed-by-mpn-patients-for-mpn-patients-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/discontinuation-of-tyrosine-kinase-inhibitors-in-chronic-myeloid-leukemia-a-randomized-national-fi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/analysis-of-clinical-and-laboratory-characteristics-of-all-with-atypical-bcrabl1-fusion-genes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/title-clinical-trial-availability-and-receipt-of-guideline-concordant-care-among-adolescents-and-yo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-pre-admission-chemotherapy-checklist-improving-timeliness-of-chemotherapy-initiation-in-a-maligna 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-3-study-inmind-of-tafasitamab-plus-lenalidomide-and-rituximab-for-relapsed-or-refractory-fol-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-fda-approved-prophylactic-treatments-for-hereditary-angioedema-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/protein-degradation-of-mycgspt1-combined-with-menin-inhibition-overcomes-resistance-to-menin-inhibi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chemotherapy-free-induction-with-pomalidomide-orelabrutinib-and-rituximab-por-followed-by-high-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/karmma-3-subgroup-analysis-in-older-patients-with-relapsedrefractory-multiple-myeloma-treated-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-study-of-treatment-landscape-and-safety-outcomes-of-us-patients-with-blastic-plasmacytoid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/minimal-residual-disease-assessment-in-hematologic-malignancies-a-systematic-review-highlighting-gl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-cladribine-plus-low-dose-cytarabine-for-relapsedrefractory-acute-myeloid-leukemia-a-mu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/maternal-and-fetal-pharmacokinetics-pk-of-pegcetacoplan-in-paroxysmal-nocturnal-hemoglobinuria-pn 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patients-with-multiple-myeloma-and-ckd-should-we-really-hold-off-on-bispecific-therapy-in-this-subg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrative-analysis-of-the-tumour-immune-microenvironment-of-breast-implant-associated-anaplastic-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-allogeneic-stem-cell-transplantation-sct-disease-characteristics-therapy-and-respo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oral-iptacopan-demonstrates-efficacy-as-salvage-therapy-for-high-risk-transplant-associated-thrombot 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fibroblast-activating-protein-as-a-biomarker-for-blood-induced-joint-inflammation-in-hemophilia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predicting-donor-engraftment-success-in-adults-post-haploidentical-bone-marrow-transplant-for-sickle 2026-08-17 monthly 0.7 https://rjrindex.com/articles/highly-efficient-collection-and-manufacture-of-autologous-hsc-gene-therapy-cell-product-for-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-need-for-a-subsequent-hct-is-a-late-amp-continuous-risk-and-with-significant-impact-in-overall 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-clinical-outcomes-in-patients-with-myelofibrosis-treated-with-pacr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/imatinib-in-mast-cell-activation-syndrome-a-retrospective-pilot-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pregnancy-outcomes-in-women-conceiving-after-hsct-for-childhood-or-adolescent-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cadance-304-a-phase-3-open-label-randomized-study-to-evaluate-the-safety-and-efficacy-of-bruton-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disease-presentation-and-immunophenotype-characteristics-in-257-patients-with-blastic-plasmacytoid-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/promising-results-from-an-ongoing-phase-i-multicenter-study-of-senti-202-a-first-in-class-cd33-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-and-safety-of-olverembatinib-hqp1351-as-second-line-therapy-in-patients-pts-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/encouraging-long-term-efficacy-and-safety-from-first-in-human-phase-1-study-of-time-limited-nvg-111 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-in-combination-with-dasatinib-prednisone-rituximab-and-blinatumomab-for-the-upfront-tre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/expansion-of-human-hematopoietic-stem-cells-by-inhibiting-translation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-addition-of-inotuzumab-ozogamicin-to-frontline-hyper-cvad-and-sequential-blinatumomab-leads-to-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-combined-with-three-day-multi-frequency-decitabine-dec3-ven-as-induction-treatment-in-n 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-rusfertide-treatment-in-polycythemia-vera-initial-results-from-the-phase-2-thrive-extensi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-inca033989-a-novel-first-in-class-mutant-calreticulin-specific-monoclonal-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/care-quality-for-patients-with-sickle-cell-disease-and-associations-with-negative-descriptors-in-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-frail-adults-treated-with-ciltacabtagene-autoleucel-in-the-real-world-a-cibm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/intravenous-iron-administration-during-sepsis-outcomes-safety-and-hemoglobin-response 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-in-combination-with-hypomethylating-agents-in-adult-patients-with-newly-diagnosed-aml-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-phase-1b-open-label-multiple-ascending-dose-study-of-om336-a-novel-bcmaxcd3 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-safety-and-mortality-outcomes-of-car-t-cell-therapies-versus-bispecific-antibodies-in-dlb 2026-08-17 monthly 0.7 https://rjrindex.com/articles/talquetamab-for-relapsedrefractory-multiple-myeloma-real-world-outcomes-from-the-us-multiple-myel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/maat013-for-ruxolitinib-refractory-acute-graft-versus-host-disease-with-gastrointestinal-involvement 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epcoritamab-r-mini-chop-results-in-2-year-remissions-and-high-mrd-negativity-rates-in-elderly-pati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/kmt2ar-but-not-other-high-risk-genetics-adversely-impacts-outcomes-in-adult-patients-with-relapsed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-lymphoma-with-antimetabolite-and-biologic-combinations-a-pharmacovigilance-analysis-using-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nanopore-sequencing-based-profiling-of-circular-rnas-in-multiple-myeloma-uncovers-circnfatc3-as-a-pr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ex-vivo-modification-of-autologous-cd34-hspcs-using-a-cd11b-directed-lentiviral-vector-encoding-apo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sasp-driven-immune-evasion-defines-a-novel-african-ancestry-associated-dlbcl-subtype-with-distinctiv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-results-of-comparison-of-low-dose-generic-dasatinib-50-mgday-versus-imatinib-400-mgday-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-the-clinical-outcomes-of-glp-1-receptor-agonists-in-untreated-indolent-non-hodgkins-lymp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aplastic-anemia-in-pregnancy-a-case-series-review-of-hematologic-parameters-treatment-and-materna 2026-08-17 monthly 0.7 https://rjrindex.com/articles/number-of-cardiac-deaths-associated-with-ibrutinib-versus-zanubrutinib-for-the-treatment-of-chronic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interleukin-27-ameliorates-inflammation-induced-chronic-pain-in-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dual-complement-and-p-selectin-inhibitor-ihp-102-prevents-lung-vaso-occlusion-in-p-selectin-defici 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterizing-hodgkin-lymphoma-survivors-shared-decision-making-across-the-care-continuum 2026-08-17 monthly 0.7 https://rjrindex.com/articles/national-alliance-of-sickle-cell-centers-consensus-recommendations-for-defining-an-adult-sickle-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/diagnostic-delays-and-misdiagnosis-patterns-in-paroxysmal-nocturnal-hemoglobinuria 2026-08-17 monthly 0.7 https://rjrindex.com/articles/title-association-of-car-t-product-type-with-incidence-of-cancer-therapy-related-cardiac-dysfunctio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transcriptional-stratification-reveals-distinct-molecular-subtypes-with-treatment-specific-outcomes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/black-lives-advocating-for-clot-knowledge-black-national-blood-clot-alliance-church-bus-tour 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bridging-the-divide-meta-analysis-of-racial-disparities-in-survival-and-clinical-trial-participatio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/neutrophil-lymphocyte-and-platelet-lymphocyte-ratios-as-predictors-of-atherosclerotic-thrombotic-ris 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-journey-with-axicabtagene-ciloleucel-for-relapsed-or-refractory-large-b-cell-lymphoma-in-can 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ttll4-glutamyltransferase-is-a-therapeutic-target-for-npm1-mutated-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/application-of-dorsal-skin-fold-chamber-microvascular-thrombosis-model-in-jak2v617f-mice 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-report-of-novel-biallelic-klf1-variants-causing-prenatal-onset-severe-transfusion-dependent-no 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-for-female-patients-with-multiple-myeloma-a-national-retrospective-trend-analysis-from-201 2026-08-17 monthly 0.7 https://rjrindex.com/articles/t-cell-replete-haploidentical-transplantation-compared-to-mismatched-unrelated-allogeneic-transplant 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cellular-senescence-associated-with-aging-and-chemotherapy-exposure-primes-bone-marrow-for-immune-dy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-of-socioeconomic-indicators-with-survival-in-chronic-myeloid-leukemia-a-retrospective-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-red-blood-cell-exchange-practices-in-the-management-of-sickle-cell-disease-across-gulf 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dark-genome-interrogation-identifies-novel-antigens-in-acute-myeloid-leukemia-developing-an-off-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-safety-and-efficacy-of-bendamustine-versus-fludarabinecyclophosphamide-prior-to-chimeri 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-car-t-cell-therapy-with-and-without-autologous-stem-cell-transplant-consolid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bi-specific-t-cell-engagers-as-a-bridge-to-ciltacabtagene-autoleucel-in-relapsedrefractory-multiple 2026-08-17 monthly 0.7 https://rjrindex.com/articles/functional-plasma-cell-signatures-mark-aml-chemotherapy-responders-evidence-from-immune-niche-profi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bifidobacterium-bx520-supplementation-prevents-neuroinflammation-in-necrotizing-enterocolitis-by-inh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-episodes-of-acute-chest-syndrom-on-the-cardiac-remodeling-in-children-and-young-adults-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-prf-1-a91v-germline-carrier-status-in-patients-with-aggressive-b-nhl-treated-with-rituxima 2026-08-17 monthly 0.7 https://rjrindex.com/articles/formalized-transition-interventions-in-adolescents-and-young-adults-with-sickle-cell-disease-a-stud 2026-08-17 monthly 0.7 https://rjrindex.com/articles/music-based-interventions-for-sickle-cell-disease-a-systematic-review-of-evidence-on-pain-mental-h 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-receptor-tyrosine-kinase-epha2-promotes-thrombogenesis-and-impairs-thrombus-resolution-in-deep-v 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-coagulation-defect-related-mortality-in-older-adults-in-the-united-states 2026-08-17 monthly 0.7 https://rjrindex.com/articles/default-one-stage-assay-for-hospitalized-hemophilia-a-patients-a-cautionary-tale 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-effect-of-recombinant-factor-viia-treatment-in-non-traumatic-intracranial-hemorrhage-systematic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-venous-thromboembolism-in-multiple-myeloma-a-nationwide-analysis-of-anticoagulation-str 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genomic-determinants-and-differences-of-primary-and-secondary-plasma-cell-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inhibition-of-prmt5-with-jnj-64619178-sensitizes-b-cell-non-hodgkin-lymphoma-cells-to-both-intrinsic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prolonged-cytopenias-after-bcma-cart-are-associated-with-impaired-endogenous-t-cell-recovery-charac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hepatic-intravital-imaging-reveals-the-contribution-of-peptidylarginine-deiminase-4-pad4-to-the-sp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/neutrophil-subpopulation-specific-ratio-and-neutrophil-extracellular-traps-are-dynamic-and-sensitive 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-treatment-znf683-effector-cd8-t-cells-predict-response-to-bite-therapy-in-acute-lymphoblastic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/toe1-influences-canonical-wnt-signalling-in-myeloid-leukaemia-cells-through-lef-1-and-regulates-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/human-hspcs-crispr-engineered-to-endogenously-express-oncogenic-nras-generate-a-transplantable-letha 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-multi-omics-uncovers-differentiation-dependent-transcriptional-programs-shaping-epigenet 2026-08-17 monthly 0.7 https://rjrindex.com/articles/frailty-as-a-prognostic-factor-in-younger-adult-patients-with-acute-myeloid-leukemia-undergoing-allo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beyond-approval-lymphoma-drugs-and-real-world-representation-2015-2025 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patterns-of-patient-referral-for-car-t-cell-therapy-increasing-access-and-changing-utilization-tren 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cumulative-cardiac-risk-strongly-predicts-in-hospital-mortality-and-cost-burden-in-patients-hospital 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gmp-compliant-generation-expansion-and-a-preliminary-safety-evaluation-of-cmv-specific-t-cells-usi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/racial-geographic-and-gender-disparities-in-ischemic-heart-disease-mortality-in-patients-with-mult 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interleukin-8-inhibition-by-reparixin-protects-megakaryocytes-and-alleviates-thrombocytopenia-in-acu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/insights-in-the-management-of-older-adults-with-mantle-cell-lymphoma-amidst-a-changing-therapeutic-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myeloidlymphoid-neoplasms-with-eosinophilia-and-tyrosine-kinase-gene-fusions-a-multi-center-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinics-and-clicks-understanding-hematology-healthcare-delivery-utilization-and-preferences-in-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-options-responses-and-outcome-of-1220-classic-hodgkin-lymphoma-patients-included-in-realy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hematological-and-inflammatory-response-trajectories-in-vexas-syndrome-patients-treated-with-hypomet 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hemolysis-impairs-hepatic-regeneration-in-sickle-cell-disease-via-altered-kupffer-cell-dynamics-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/second-primary-malignancy-in-multiple-myeloma-a-retrospective-monocentric-analysis-of-department-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-prognostic-analysis-of-non-intensive-chemotherapy-in-symptomatic-versus-asy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/propensity-score-matched-comparison-of-outcomes-following-treatment-with-pola-r-chp-versus-r-chop-fo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targets-of-btk-and-irak4-pathways-in-cns-lymphoma-identification-of-cxcl10-as-a-prognostic-biomarke 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-acting-gm-csf-based-drug-conjugate-effectively-targets-leukemia-stem-cells-in-acute-myeloid-leu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inferior-vena-cava-agenesis-presenting-as-iliofemoral-deep-vein-thrombosis-in-a-49-year-old-male 2026-08-17 monthly 0.7 https://rjrindex.com/articles/monte-carlo-simulation-of-hla-dq-heterodimers-and-their-interactions-to-predict-relapse-and-gvhd-ris 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dna-sequencing-outperforms-rna-sequencing-for-comprehensive-fusion-detection-in-lymphoma-diagnostics 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-and-immune-dysregulation-in-classic-pnh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unannotated-open-reading-frames-expand-the-antigen-repertoire-in-t-cell-acute-lymphoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomic-analysis-of-chronic-lymphocytic-leukemia-lymph-nodes-reveals-tumor-microenvir 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-overall-survival-among-patients-with-high-risk-mds-insights-from-the-spanish-mds 2026-08-17 monthly 0.7 https://rjrindex.com/articles/functional-classification-of-monoallelic-tp53-mutations-refines-prognostic-stratification-in-myelody 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dnmt3a-driven-clonal-hematopoiesis-permits-colitis-associated-tumorigenesis-by-promoting-innate-immu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improved-survival-in-patients-with-multiple-myeloma-over-time-a-retrospective-single-center-study-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/second-primary-malignancies-in-multiple-myeloma-incidence-survival-and-prognostic-factors-from-a-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/red-cell-indices-in-adolescents-with-iron-deficiency-and-heavy-menstrual-bleeding 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-nucleus-dissection-of-peripheral-t-cell-lymphomas-reveals-distinct-microenvironmental-ecosyst 2026-08-17 monthly 0.7 https://rjrindex.com/articles/wstf-degradation-through-nuclear-autophagy-promotes-inflammatory-responses-in-primary-myelofibrosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/old-mismatched-donors-are-associated-with-inferior-outcomes-after-allogeneic-hematopoietic-stem-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vedolizumab-for-steroid-refractory-gastrointestinal-acute-graft-versus-host-disease-a-real-world-va 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pomalidomide-rituximab-and-orelabrutinib-in-combination-with-polatuzumab-vedotin-for-newly-diagnos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/teclisito-low-intensity-teclistamab-in-the-outpatient-setting-for-relapsedrefractory-multiple-myel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/synergistic-integration-of-car-t-cell-pharmacokinetics-and-ngs-mrd-evolution-enables-precision-risk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/results-of-the-apg2575au101-study-of-lisaftoclax-apg-2575-combined-with-azacitidine-aza-in-patie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blinatumomab-and-ponatinib-demonstrates-ongoing-efficacy-as-frontline-therapy-in-philadelphia-positi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/updated-response-and-safety-analyses-from-a-phase-1-study-of-ivosidenib-combined-with-intensive-chem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-or-pirtobrutinib-in-relapsedrefractory-waldenstrom-macroglobulinemia-clinical-and-molec 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cytogenetics-based-clinical-trajectories-of-patients-with-mrd-negativity-post-autologous-stem-cell-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disease-stigma-and-salivary-stress-biomarkers-among-adolescents-and-young-adults-with-sickle-cell-di 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comprehensive-profiling-of-the-bone-marrow-microenvironment-reveals-an-exhausted-immune-signature-as 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-ccl3mono-like-lsc-overcomes-chemotherapy-resistance-in-npm1-mutant-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aromatherapy-oil-during-bone-marrow-biopsy-procedure-and-association-with-anxiety-and-pain-an-inter 2026-08-17 monthly 0.7 https://rjrindex.com/articles/healthcare-resource-utilization-in-patients-receiving-quizartinib-or-placebo-in-combination-with-che 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-bone-marrow-sample-quality-derived-using-a-non-redirection-versus-a-traditional-bone-marr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/serum-albumin-but-not-gnri-is-an-independent-prognostic-factor-for-survival-after-first-allogeneic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/refined-design-of-a-cd117-antibody-drug-conjugate-safely-and-effectively-conditions-non-human-primat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-novel-therapies-for-sickle-cell-disease-a-network-meta-analysis-of-hydroxyu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/stability-of-adamts13-activity-in-liquid-plasma-and-its-clinical-application-in-therapeutic-plasma-e 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-maintenance-therapy-with-iberdomide-after-autologous-hematopoietic-cell-transplant 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-clinical-efficacy-of-venetoclax-in-combination-with-azacitidine-in-patients-with-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-2-study-of-dapolsertib-men1703-sel24-as-monotherapy-and-in-combination-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/f1-subunit-specific-atp-synthase-inhibition-disrupts-aml-mitochondrial-metabolism-distinctly-from-ot 2026-08-17 monthly 0.7 https://rjrindex.com/articles/asciminib-in-chronic-myeloid-leukemia-superior-efficacy-and-favorable-safety-outcomes-from-a-system 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploring-the-relationship-between-health-related-stigma-and-perceived-discrimination-among-adults-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/implementing-linkage-coordination-patient-experiences-in-the-recruitment-and-engagement-in-care-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blinatumomab-versus-high-dose-chemotherapy-in-the-first-line-therapy-of-high-risk-childhood-b-cell-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-phase-1-study-to-evaluate-the-safety-and-preliminary-efficacy-of-arlocabtagene 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prevalence-and-timing-of-iron-deficiency-among-youth-with-sickle-cell-disease-receiving-chronic-tran 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-cachexia-hematologic-severity-score-chess-use-of-a-laboratory-based-tool-to-predict-survival 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrative-clinical-and-molecular-analysis-of-outcome-in-elderly-african-ancestry-acute-myeloid-leu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longer-telomeres-in-donors-aged-35-years-reduce-graft-failure-and-non-relapse-mortality-after-allog 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-humanistic-burden-of-patients-with-chronic-myeloid-leukemia-cml-treated-with-first-line-1l-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/physicians-perceptions-of-fixed-duration-epcoritamab-lenalidomide-and-rituximab-regimens-in-relaps 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-teclistamab-for-multiple-myeloma-in-canada-multi-institutional-report-from-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-toxicities-of-talquetamab-tal-in-relapsedrefractory-multiple-myeloma-rrm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-anti-mpl-antibody-amm2-prevents-cardiovascular-dysfunction-in-a-mouse-model-of-myeloproliferativ 2026-08-17 monthly 0.7 https://rjrindex.com/articles/differences-in-insurer-payments-for-hematology-part-b-drugs-between-traditional-medicare-and-medicar 2026-08-17 monthly 0.7 https://rjrindex.com/articles/modification-of-post-trogocytosis-effects-to-enhance-car-t-cell-persistence 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rituximab-cyclophosphamide-mitoxantrone-hydrochloride-liposome-vincristine-and-prednisone-r-cmo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-2-trial-of-cpx-351-vs-clag-m-cladribine-high-dose-cytarabine-g-csf-and-mitox 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploratory-study-iron-trends-in-aging-women-with-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anti-cd38-immunotherapy-assay-and-monitoring-in-patients-with-multiple-myeloma-a-monocentric-pilot 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tracking-peripheral-residual-disease-in-myeloma-clonotypic-sequencing-and-mass-spectrometry-in-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-platelet-activating-hpa-1a-specific-maternal-alloantibody-identifies-a-pathogenic-subpopulation-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identifying-epigenetic-vulnerabilities-for-treatment-of-hma-refractory-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cardiotoxicity-profile-of-novel-bispecific-t-cell-engager-therapies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combined-kit-d816v-and-hat-blood-testing-development-and-validation-of-a-targeted-non-invasive-work 2026-08-17 monthly 0.7 https://rjrindex.com/articles/successful-retreatment-of-pnh-with-switch-to-ravulizumab-and-add-on-danicopan-after-experiencing-bre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/metabolic-reprogramming-via-targeting-the-medium-chain-fatty-acid-receptor-enhances-the-anti-tumor-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acquired-hemophilia-a-aha-associated-with-monoclonal-gammopathy-a-single-institution-case-series 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-syngeneic-transplantation-in-multiple-myeloma-valuable-legacy-or-obsolete-opt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-in-frail-and-non-frail-patients-with-newly-diagnosed-mult 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acalabrutinib-vs-zanubrutinib-as-first-line-therapy-in-cll-a-propensity-score-matched-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/representativeness-of-clone-size-measurement-by-using-ngs-based-immunoglobulin-gene-rearrangement-te 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myeloid-malignancies-molecular-analysis-for-therapy-choice-myelomatch-rapid-availability-of-clini 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pharmacometric-analyses-supporting-apixaban-doses-in-neonates-with-venous-thromboembolism 2026-08-17 monthly 0.7 https://rjrindex.com/articles/use-of-angiopoietin-2-as-a-biomarker-in-vascular-anomalies-beyond-complex-lymphatic-anomalies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/physician-reported-impact-of-vaso-occlusive-crises-in-people-with-sickle-cell-disease-a-multination 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-safety-and-efficacy-of-the-frida-study-iadademstat-and-gilteritinib-in-flt3-mutated-rel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-with-car-t-therapy-in-relapsedrefractory-multiple-myeloma-and-severe-renal-fail 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-untargeted-baseline-plasma-metabolomics-in-newly-diagnosed-diffuse-large-b-cell-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-reparixin-in-patients-with-myelofibrosis-myeloproliferative-neoplasms-research-co 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-second-primary-malignancies-in-myelofibrosis-pre-and-post-jak-inhibitor-era-a-surveillan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-switching-to-olverembatinib-or-continuing-original-tki-therapy-in-cml-cp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/flumatinib-versus-nilotinib-as-first-line-therapy-for-chronic-myeloid-leukemia-in-chronic-phase-a-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploring-co-mutations-in-cml-and-ph-b-all-with-abl1-variants-correlations-with-survival-and-tre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characteristics-and-clinical-outcomes-of-nd-aml-patients-with-bcorbcorl1-mutations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pu1-cebpa-ratio-directed-reprogramming-converts-b-all-cells-into-stable-m1-macrophages-for-scalab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/protein-expression-signatures-reveal-age-specific-risk-patterns-in-b-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-pityriasis-rubra-pilaris-with-hematological-malignancies-paraneoplastic-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patients-with-high-risk-features-in-mantle-cell-lymphoma-a-systematic-literature-review-of-clinical 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-blood-endothelial-cells-shape-spatial-niches-in-angioimmunoblastic-t-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/manual-review-of-select-hotspots-may-unmask-clonal-hematopoiesis-variants-at-low-levels-in-at-risk-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/amlsp-model-for-aml-survival-prediction 2026-08-17 monthly 0.7 https://rjrindex.com/articles/national-practice-patterns-and-preferences-in-the-use-of-fixed-duration-vs-treat-to-progression-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/selinexor-based-non-intensive-chemotherapy-regimens-adjusted-according-to-early-responses-achieve-hi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-pola-r-chp-for-untreated-diffuse-large-b-cell-lymphoma-dlbcl-a-systematic-liter 2026-08-17 monthly 0.7 https://rjrindex.com/articles/frailty-markers-associated-with-impaired-survival-and-hospitalization-outcomes-for-patients-with-agg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fviii-associated-ldl-circulates-longer-and-participates-in-blood-clot-formation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/endogenous-and-therapeutic-transport-of-activated-protein-c-across-the-blood-retina-barrier-protects 2026-08-17 monthly 0.7 https://rjrindex.com/articles/metabolic-reprogramming-drives-acquired-venetoclax-resistance-in-acute-myeloid-leukemia-and-reveals 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-heme-pathway-a-possible-metabolic-target-for-the-treatment-of-hematologic-cancers 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pirtobrutinib-versus-usual-care-for-patients-with-richter-transformation-of-chronic-lymphocytic-leuk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-upfront-blinatumomab-combined-with-reduced-intensity-chemotherapy-for-newly-diagnosed-ad 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hematological-symptom-burden-and-treatment-patterns-in-patients-with-igg4-related-disease-a-real-wo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aspirin-use-among-patients-with-thrombotic-antiphospholipid-antibody-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/does-stroke-or-silent-infarct-affect-quality-of-life-in-adults-with-sickle-cell-disease-a-multi-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-an-optimal-absolute-lymphocyte-count-before-bispecific-antibody-therapy-for-large 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-between-inhibitor-screen-and-mini-bethesda-assay-to-diagnose-low-titre-inhibito 2026-08-17 monthly 0.7 https://rjrindex.com/articles/factor-xi-haploinsufficiency-is-protective-against-venous-thromboembolism-and-myocardial-infarction 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-of-red-blood-cell-transfusion-and-clinical-outcomes-in-chimeric-antigen-receptor-t-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-interactive-database-containing-all-known-variants-in-adamts13-yields-new-insight-into-the-geneti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-allo-hsct-in-setcan-positive-hematological-malignancies-a-12-year-single-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gata-3-identifies-a-distinct-subset-of-t-cell-prolymphocytic-leukemia-t-pll-and-is-associated-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-pre-ngs-screening-strategy-to-identify-populations-with-high-risk-clonal-hematopoiesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/social-determinants-of-health-and-outcomes-in-patients-with-acute-leukemia-interim-results-from-a-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-cardiovascular-risk-of-ponatinib-in-chronic-phase-cml-insights-from-a-nationwide-korean 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thyroid-diffuse-large-b-cell-lymphoma-in-china-multicenter-study-of-diagnosis-clinical-features-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-earlier-chr-achievement-and-long-term-chr-maintenance-in-polycythemia-vera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/human-intestinal-acute-graft-versus-host-disease-is-governed-by-a-subset-of-transition-like-tissue-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/type-2-diabetes-screening-and-management-in-individuals-with-sickle-cell-disease-is-compromised-by-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/whole-genome-sequencing-of-cell-free-dna-for-assessment-of-minimal-residual-disease-in-high-risk-smo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cly-124-a-first-in-class-dcn1-inhibitor-partially-suppresses-cul3-neddylation-and-induces-fetal-hem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-inobrodib-ccs1477-in-combination-with-teclistamab-or-elranatamab-in-patients-with-relap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessing-the-prevalence-of-sickle-cell-retinopathy-in-clinical-practice 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trials-in-progress-phase-ibii-of-cpx-351-as-maintenance-therapy-in-aml-patients-ineligible-for-bon 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-report-a-novel-deep-intronic-mutation-and-treatment-using-hetrombopag-olamine-of-a-patient-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-marstacimab-treatment-in-adolescent-participants-with-hemophilia-a-or-b-without-inhibito 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-fixed-duration-venetoclax-based-regimens-as-first-line-in-chronic-lymphocytic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-zanubrutinib-maintenance-in-patients-with-primary-cns-lymphoma-achieving-complete-respon 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-adherence-to-cervical-cancer-screening-guidelines-among-women-survivors-after-allogeneic-hematop 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-of-anxiety-and-depression-with-cannabis-usage-disorder-among-thalassemia-patients-a-nat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-voxelotor-in-sickle-cell-disease-a-comprehensive-meta-analysis-of-hemoglobin-response 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-l-glutamine-for-reducing-complications-in-sickle-cell-disease-a-systematic-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/can-a-patient-questionnaire-vrat-reduce-the-need-for-ocular-examinations-with-less-frequent-belant 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-mortality-from-chronic-lymphocytic-leukemia-in-the-geriatric-population-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-prognostic-determinants-of-btk-inhibitors-in-chronic-lymphocytic-leukemia-cll-a-real 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cxcr6-dependent-ilc3-migration-to-the-intestinal-stem-cell-compartment-promotes-epithelial-regenerat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-galileo-3-a-phase-3-safety-and-efficacy-trial-of-flt201-gene-therapy-in-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-between-circadian-rhythm-disruption-and-hematopoietic-function-in-patients-with-hematolo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-and-comorbidity-of-myelodysplastic-syndromes-among-usadults-with-heart-failure 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gut-microbiota-recovery-via-butyrate-supplementation-prevents-acute-graft-versus-host-disease-after 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-cd19cd22cd20-multi-targeted-car-t-therapy-in-patients-with-refractoryrelap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/feasibility-outcomes-and-challenges-of-car-t-cell-therapy-as-advanced-or-earlier-line-of-treatment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sickle-cell-disease-trials-redefined-toward-unified-clinical-endpoints-through-international-consen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognosis-prediction-beyond-mtv-using-easy-to-calculate-parameters-derived-from-fdg-petct-a-pilot 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-survival-outcomes-in-patients-with-mantle-cell-lymphoma-interim-report-of-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/naive-cd4-at-apheresis-and-disease-control-at-infusion-are-associated-with-improved-efficacy-in-sec 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-mp0533-a-tetra-specific-t-cell-engager-cd33-x-cd123-x-cd70-x-cd3-in-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-whole-brain-radiotherapy-is-a-safe-and-effective-backbone-in-primary-central-nervous-system-lymp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myc-dependent-permissiveness-of-pi3k-hyperactivation-renders-metabolic-vulnerability-in-rr-b-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/systematic-review-of-non-icans-neurological-toxicities-associated-with-bcma-and-gprc5d-directed-car 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-actionable-dna-repair-defect-in-myeloid-malignancies-with-u2af1-s34-mutations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-validation-of-a-high-sensitivity-method-to-detect-residual-disease-in-blood-of-treated-myel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-kmt2a-ptd-oncoprotein-depends-on-enl-but-not-menin-to-drive-aml-gene-expression 2026-08-17 monthly 0.7 https://rjrindex.com/articles/results-of-the-first-latin-american-point-of-care-manufactured-phase-i-anti-cd19-car-t-study-cart 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improved-outcomes-with-low-dose-hypomethylating-agent-plus-venetoclax-as-post-transplant-maintenance 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-12-studies-of-dzd8586-in-cllsll-patients-after-covalent-and-non-covalent-btk-inhibitors-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-efficacy-and-safety-of-the-bruton-tyrosine-kinase-degrader-bgb-16673-in-patients-with-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/axi-cel-delivers-similar-outcomes-regardless-of-asct-eligibility-in-second-line-rr-lbcl-combined-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-enhanced-prognostication-in-rare-acute-myeloid-leukemia-subtypes-with-bcra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/promising-response-rates-and-manageable-safety-with-mosunetuzumab-plus-lenalidomide-mosun-len-in-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mosunetuzumab-in-combination-with-zanubrutinib-is-safe-in-patients-with-relapsedrefractory-follicul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/analysis-of-immune-parameters-and-effect-of-immunoglobulin-replacement-therapy-on-infection-surviva 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beyond-the-trial-real-world-crs-icans-and-healthcare-burden-of-car-t-cell-therapy-across-us-oncol 2026-08-17 monthly 0.7 https://rjrindex.com/articles/flt3-itd-ngs-mrd-refines-risk-stratification-in-npm1-and-flt3-co-mutated-aml-beyond-npm1-pcr-mrd-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-compelling-case-for-central-pathology-review-of-multiparameter-flow-cytometry-measurable-residual 2026-08-17 monthly 0.7 https://rjrindex.com/articles/golcadomide-golca-a-potential-first-in-class-oral-celmod-agent-rituximab-r-in-patients-wi-1 2026-08-17 monthly 0.7